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 Novel intracellular drug delivery techniques are needed to overcome the barrier of 
the cell’s plasma membrane. Since the cell membrane is highly selective, it is difficult for 
potential therapeutics, like those for gene-based therapy and other active molecules to enter 
the cytosol by methods other than active transport. To bypass the membrane, physical drug 
delivery methods can be employed to create transient openings in the membrane that enable 
the passive transport of molecules. Optimizing physical methods is often challenging due 
to a need to balance molecular delivery and high cell viability. A novel, laser-mediated 
technique known as transient nanoparticle energy transduction (TNET) has been shown to 
successfully balance these two parameters. When carbon black (CB) nanoparticles in 
suspension with cells and small molecules are irradiated by nanosecond-pulsed near 
infrared (NIR) laser energy, efficacious delivery while maintaining high cell viability are 
achieved. 
 This novel drug delivery platform is driven by the laser-activation of CB 
nanoparticles and the subsequent energy transduction which induces bioeffects (i.e., uptake 
and viability loss). Upon NIR absorption, the CB nanoparticles rapidly heat up to hundreds 
of degrees Celsius and undergo thermal expansion. This rapid heating leads to vaporization 
of surrounding water, which creates vapor-bubbles that transfer heat and pressure to nearby 
cells. To gain mechanistic insight into TNET, we studied various aspects of this in vitro 
system, including cellular mechanics, cell-CB nanoparticle interaction, and the role of 
photoacoustics. 
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 First, we studied the role of cellular mechanics in TNET by way of the cytoskeleton 
and plasma membrane fluidity. Destabilizing the cytoskeleton of DU145 cells caused 
greater intracellular uptake and lower viability loss compared to cells with intact 
cytoskeletons. Additional studies showed that altering the fluidity of the membrane had no 
significant effect on bioeffects. From these studies, we concluded that cytoskeletal 
mechanics are integral to resulting bioeffects achieved with TNET, whereas the fluidity of 
the plasma membrane is not.  
 Next, we studied the effect of energy input into the system, which was increased by 
increasing laser fluence, CB nanoparticle concentration and number of laser pulses. We 
found that at low energy, intracellular uptake increased with increasing energy input. At 
higher energy, cell viability loss of DU145 cells increased and viable cells with 
intracellular uptake decreased. At the highest energy inputs, cell fragmentation increased, 
while intracellular uptake and loss of viability decreased. Increasing cell concentration had 
the opposite effect (i.e., it reduced the intensity of bioeffects), which suggests that 
neighboring cells shielded each other from the effects of TNET. Increasing medium 
viscosity also decreased the intensity of bioeffects, suggesting a mechanical (i.e., not 
thermal) cause of bioeffects.  
 Finally, we studied the effects of three different carbon-based nanoparticles – CB, 
multi-walled carbon nanotubes (MWCNT) and single-walled (SWCNT) carbon nanotubes 
– on DU145 cellular bioeffects. As mentioned above, increasing energy input with CB 
nanoparticles progressed through increasing intracellular uptake, followed by increasing 
cell viability loss, which was followed by increasing cell fragmentation. For MWCNT, 
increasing energy input first increased intracellular uptake and then increased cell 
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fragmentation, but did not cause cell viability loss. For SWCNT, no significant bioeffects 
were seen, except at extreme conditions where cell viability loss was seen.  The intensity 
of photoacoustic output in the form of a single, mostly positive-pressure pulse of ~100 ns 
duration varied among the different types of nanoparticles, where SWCNT had the highest 
peak pressure, followed by CB and then by MWCNT. Lack of a universal correlation 
between peak pressure and cellular bioeffects, suggested that total energy input rather than 
pressure output was more mechanistically relevant to TNET. 
 Overall, this work provides functional characterization and mechanistic 
understanding the cellular bioeffects cause by TNET. These studies will contribute an 
understanding of TNET that will enable rational design of TNET systems for future 







CHAPTER 1. INTRODUCTION 
Drug delivery research seeks to address the challenges of increasing healthcare 
costs and a growing need for novel therapies to treat complex diseases [1], [2]. Molecules 
such as proteins, nanocarriers, and plasmids are potentially revolutionary forms of 
therapies. Yet, for these treatments to be effective, they must be delivered into the 
cytoplasm or the nucleus [3]–[5]. The lipophilic nature of the cell membrane, however, is 
a delivery barrier for these molecules. The cell membrane resists the delivery of large or 
polar molecules across the membrane and into the cytosol by processes other than active 
transport (e.g. endocytosis) [6], [7]. Endocytosis is a process in which the cell engulfs 
external molecules. Due to changes in pH and other degradative processes, this process can 
cause degradation of the drug molecule or release of the comprised drug into the cytoplasm, 
which can face further obstacles with cytoplasm trafficking and access to the nucleus [8].  
Drug delivery researchers employ a number of techniques to overcome the cell 
membrane barrier. These methods can be divided broadly into biological, chemical, and 
physical drug delivery methods, all which have varying advantages and drawbacks. 
Briefly, biological and chemical methods can be disadvantageous due to issues with 
cytotoxicity [9]–[12] and delivery processes mediated by endocytosis [8]. In contrast, 
physical methods bypass the endocytic pathway by applying physical forces to the cell 
membrane and create transient openings which drive molecules into the cytosol. 
Physical drug delivery methods include electroporation, microinjection, ultrasound, 
and laser-mediated methods. These methods are advantageous because they can be applied 
generically to different types of cells and tissue systems. Yet, a major drawback associated 
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with physical methods is balancing molecular delivery and cell viability. Forces applied to 
the cell can cause irreversible damage and result in viability loss. Thus, truly effective 
physical methods attain high intracellular delivery and high cell viability. This work uses 
a novel laser-mediated method which achieves efficacious drug delivery with laser-
activated carbon nanoparticles. 
When carbon black (CB) nanoparticles in suspension with cancer cells and small 
molecules are irradiated by nanosecond pulsed, near-infrared (NIR) laser energy, high 
cellular uptake and high viability can be achieved [13], [14]. This approach was inspired 
by Chen and Diebold’s [15] studies of laser-irradiated CB nanoparticles which produced a 
“giant photoacoustic effect.” The photoacoustic effect was caused by rapid particle heating, 
thermal expansion and generation of vapor bubbles due to a carbon-steam reaction with the 
surrounding liquid [15]. Laser-mediated delivery with CB nanoparticles was a departure 
from previous work with ultrasound drug delivery, where it was difficult to achieve 
effective delivery, while minimizing viability loss [16]–[22]. 
First, Chakravarty [13] used femtosecond and nanosecond laser pulses to deliver 
molecules such as dextran and bovine serum albumin intracellularly, and hypothesized that 
intracellular delivery was driven by Diebold’s observed photoacoustic effect and the 
carbon-steam reaction [15] . Later efforts by Sengupta [23] discovered that the chemical 
reaction was not the primary driver for observed bioeffects. They hypothesized that 
observed bioeffects were due to an acoustic and/or thermal mechanism because of rapid 
vapor bubble formation and expansion on the timescale of the nanosecond pulse. It was 
postulated that these combined energy mechanisms, phenomena known as transient 
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nanoparticle energy transduction (TNET), were responsible for high molecular delivery 
and high cell viability. 
The aforementioned work provided an important foundation to understand energy 
transfer from the particle to the cell. Sengupta’s work [23] concluded that neither the 
thermal expansion of the particle nor long-range acoustics were mechanistically 
responsible for TNET [23]. Instead, it was proposed that short-range interactions due to 
cell – particle interaction caused the observed bioeffects of TNET. In turn, this dissertation 
builds on that prior work and seeks to provide a more thorough biophysical basis for TNET 
and its effects on cells. 
The first part of this study focused on understanding the role of a cell’s mechanical 
integrity due to TNET. In this work, we explored cytoskeletal mechanics and cell 
membrane fluidity by altering their proprieties and then testing the resulting bioeffects (i.e. 
intracellular uptake and viability) with in vitro exposures. Actin filaments in the 
cytoskeleton were weakened with Latrunculin A and rigidified using Jasplakinolide. Cell 
membrane fluidity was increased with methyl-β-cyclodextrin and decreased with water-
soluble cholesterol.  
The second part of this work tested various parameters which facilitate short-range 
cell-CB nanoparticle interaction, while elucidating their mechanistic implications for 
TNET. The effect of total energy input on this interaction was studied by evaluating the 
effects of laser pulse, fluence, CB nanoparticle concentration, cell concentration and 
medium viscosity.  
Lastly, we investigated the long-range effects of acoustically active carbon 
nanoparticles and the resulting cumulative pressure-field. In this study, we attempted to 
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separate bioeffects from the influence of the nanoparticle. First, we measured the 
cumulative pressure profiles of three carbon particle systems – CB, single-walled carbon 
nanotubes (SWCNT), and multi-walled carbon nanotubes (MWCNT). Then, to determine 
if bioeffects correlate with long-range acoustic output, we tested the three particle systems 
in vitro and quantified the resulting bioeffects (i.e. uptake and viability).  
The overall aim of this dissertation is to provide a fundamental mechanistic 
understanding of energy transductions in TNET that impact cells. This will enable a more 
rational approach in future optimization of this platform that will be necessary before 
translating TNET for laboratory applications, in vivo and eventually into the clinic.  
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CHAPTER 2. BACKGROUND 
Innovative drug delivery research is necessary to treat complex diseases [2], [24]. 
Specific targeting of drugs is challenging due to the cell membrane. The cell membrane 
resists polar molecules and prevents the diffusion of large molecules across the membrane 
[7]. Researchers including scientists, engineers, clinicians, and pharmacists are developing 
techniques that will effectively deliver the active substance to highly targeted sites [4], [5]. 
Revolutionary gene therapy via siRNA and mRNA [8], [25], in addition to innovative 
active substances [26] are potentially more potent therapies if they reach the cytosol. Thus, 
targeting of drugs into cells is essential for the advancement of not only drug delivery, but 
more broadly for the advancement of human health.  
2.1 Transport mechanisms to cross the plasma membrane barrier 
2.1.1 Passive transport mechanisms 
Phospholipids compose the cell membrane and provide a barrier between the cell 
and its external environment (Figure 2.1). The phospholipids contain polar head groups 
and fatty acid tails which facilitate transport of ions and molecules across the membrane. 
Selective permeability of the cell membrane is a result of the tightly packed phospholipids 
and the hydrophobic interior (i.e. due to fatty acid tails). Thus, only select molecules can 
move freely across the membrane without energy expenditure of the cell. Molecules that 
are small, nonpolar, and uncharged can cross the membrane via passive transport. Passive 
transport can be designated into three categories – (i) diffusion, (ii) facilitated diffusion, 
and (iii) osmosis.  
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Figure 2.1: Schematic of lipid bilayer showing components of phospholipids that are 
present in the cell membrane. Adapted from [27].  
Diffusion allows small molecules like O2 can freely pass through small holes in 
cell membrane surface. Diffusion is simply the movement of molecules or particles due to 
a concentration gradient in an energetically more favorable direction [28]. Charged, polar, 
or larger molecules cannot pass through the membrane by simple diffusion. Facilitated 
diffusion transports these types of molecules by transmembrane proteins consisting of 
channel proteins and carrier proteins. Channel proteins form small pores regulated by the 
cell’s response to external stimuli and allow ions like Ca2+ and K+ to diffuse across the cell 
membrane [28]. Molecules that cannot cross due to size or polarity, like glucose are 
transported by carrier proteins. Carrier proteins are activated when water-soluble molecules 
like glucose selectively bind to the protein, change its confirmation and results in the 
transport of the molecule from the external surface to the cell interior. Finally, osmosis is 
the process in which molecules in water freely diffuse in and out of the cell, regulated by 
the water potential exerted on the membrane.  
2.1.2 Active transport mechanisms 
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If a molecule must cross the cell membrane against the concentration gradient, the 
cell must expend energy in the process, which is known as active transport. The cell uses 
transmembrane proteins or the cell membrane for active transport mechanisms. 
Transmembrane proteins are used in the sodium-potassium pump (i.e. Na+/K+ ATPase), 
where the cell transports sodium out of the cell and moves potassium into the cell to 
maintain an electrical gradient across the cell membrane [28]. Active transport can also 
occur without the assistance of transmembrane proteins (e.g. endocytosis).  
Endocytosis is an active transport mechanism for intracellular uptake of molecules 
that cannot cross the membrane due to size, charge and/or polarity. Endocytosis occurs 
when the cell membrane extends itself, engulfs external molecules, and pinches that part 
of the membrane off into a vesicle. For general uptake of molecules, the cell can use 
phagocytosis or pinocytosis to bring external molecules to its interior. Phagocytosis engulfs 
large molecules and is commonly used by immune cells such as macrophages, which 
actively engulf foreign matter in tissues [29]. Pinocytosis, unlike phagocytosis, engulfs 
external fluid containing dissolved molecules for transport into the cell [29]. For more 
selective intracellular uptake, the cell can employ receptor-mediated endocytosis. In 
receptor-mediated endocytosis, receptors must bind to a specific surface ligand before the 
cell endocytoses the receptor-ligand complexes [29].  
2.2 Intracellular delivery techniques addressing challenge of intracellular targeting 
The inherent structure of the cell poses challenges for intracellular targeting of 
therapeutics. Because the cell membrane is highly selective, most drug molecules of 
interest, ranging from small molecules to larger molecules such as DNA and RNA, are not 
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able to pass through the membrane through passive processes. To overcome the plasma 
membrane, various drug delivery techniques have been developed which either (i) harness 
the cell’s active transport mechanisms or (ii) disrupt the cell membrane to enable passive 
transport of molecules. 
Chemical and biological drug delivery methods harness endocytosis to deliver 
therapeutics intracellularly [30]. Chemical methods modify a drug to assist crossing the 
membrane, whereas biological drug delivery methods (i.e. viruses) use the machinery of 
the virus to cross the cell membrane. However, a major drawback of endocytosis is possible 
lysosomal degradation that can occur in the endocytic pathway [8]. In the endocytic 
pathway, endosomes expose the drug to low pH and can irreversibly damage the drug.  
In contrast, physical methods bypass active transport methods by breaking holes in 
the cell membrane to enable passive transport of molecules into the cell [31]. By creating 
transient pores in the membrane, the drug can cross the cell membrane through passive 
transport and bypass potential degradation from the endocytotic pathway.  
The following section will review more in detail the three major delivery techniques 
– chemical, biological and physical, which are used to target therapies intracellularly. 
2.2.1 Chemical methods 
Chemical methods are used to modify a drug and improve its overall stability. 
Encapsulation of the drug can assist in crossing the plasma membrane by active transport 
for delivery into the cytosol. Several approaches to encapsulate a drug include polymer 
micro/nano capsules made by layer-by-layer assembly [4], [24], [32], [33], hydrogels [4], 
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[24], peptides with nanoparticles [4], [34], and cationic lipids. These approaches can 
increase the precision of targeting and may improve release profiles of the drug [4].  
Nanoparticles and cationic lipids have different capabilities dependent on their 
design. Nanoparticle design can vary based on the material, ranging from inorganic 
materials [35] to polymers [36] (i.e. liposomes [37], dendrimers [38]), and nanocrystals 
[39]. These materials allow for multifunctional targeting and sometimes imaging 
capabilities [35]. Cationic lipids can be assembled into liposomes [12], [40] which facilitate 
endocytic uptake and escape. Cationic lipids can disrupt the cell membrane via electrostatic 
interactions with membrane phospholipids [10], [41]. Chemical techniques pose a variety 
of disadvantages, due to stability, clearance, toxicity [10]–[12], and lysosomal degradation 
[8]. 
2.2.2 Biological methods 
Biological methods include areas of gene delivery, specifically viral vectors that 
express transgenes for therapy. There are several types of vectors used for biological 
methods –retroviruses, lentiviruses, and adenoviruses [9]. Virus particles can be used for 
DNA and RNA delivery, in which viral vectors infect cells and then replicate their viral 
genome to induce gene expression [9], [42]. While viral vectors hold great promise for 
therapy, there are rampant issues with immune matching and excessive costs associated 
with this method of drug delivery [9]. Like chemical methods, these biological methods 
promote endocytotic uptake, and thus have issues with intracellular delivery since it is 
mediated by the endocytotic pathway. 
2.2.3 Physical methods 
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Biophysical methods leverage physical stresses to disrupt the cell membrane and 
drive drug molecules across the membrane. Physical methods are particularly 
advantageous because they bypass the membrane, avoid the endocytotic pathway, and 
provide a clear pathway for targeting the cytosol [31], [43]. However, there are also 
substantial challenges associated with physical methods. The challenge is to control the 
magnitude of physical stress imparted onto the cell while balancing intracellular delivery 
and cell viability. These stresses which create transient openings or pores, can sometimes 
lead to cell death if the pores cannot reseal and/or the cell cannot recover from the stress.  
Pores created by physical disruption of the membrane can be characterized 
according to their spatial and temporal response. Transient pores and pores that exist 
beyond the transient timeframe can trigger the onset of apoptosis or necrosis [19]. 
However, pores that can repair themselves, may be able to retain the cells’ viability. More 
specifically, pores that are unstable and reseal themselves exist on a short time span and 
are very small (i.e. 1 nm). In contrast, pores that are open longer and are larger (i.e. 10 – 
100 nm), require active resealing by the cell. To patch these larger pores, the cell uses 
active cellular process to ‘patch-up’ wounds in the membrane. For example, pores on this 
scale are observed in ultrasound drug delivery research due to violent cavitation events 
[21], [22], [44]. Pores that are 1 – 10 nm are often metastable and undergo passive 
resealing. This scenario arises due to an increase in free energy when water enters the pores 
and interacts with the hydrophobic tail interior region of the membrane. Because this 
interaction is unfavorable, the lipids passively reshape themselves to minimize free energy 
[45]. These types of pores have been studied extensively in electroporation mediated 
methods and have been shown to exist on the timescale of milliseconds [46]–[48]. 
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Nevertheless, different biophysical methods can result in pores with the aforementioned 
characteristics. Relevant physical methods which create these types of pores include 
electroporation, ultrasound, microinjection, and laser-assisted delivery. 
2.2.3.1 Electroporation 
Electroporation is a popular biophysical technique used for cell transfection. 
Electroporation occurs when a short, high-voltage pulse is applied to a cell and the resulting 
electric field leads to membrane disruption [47]. The disruption creates pores that enable 
the delivery of molecules across the membrane. This method has successfully delivered a 
wide range of molecules, e.g. DNA, and proteins [47], and has shown promise with in vitro 
and in vivo methods [49], [50]. However, electroporation can be challenging to translate 
due to empirical optimization that is cell type dependent and in need for invasive electrodes 
for application to tissues [47].  
2.2.3.2 Ultrasound 
Ultrasound has been used to deliver genetic materials and chemotherapies into cells 
by means of acoustic cavitation to mechanically disrupt cell membranes [18], [19], [22]. 
Cavitation occurs when a bubble collapses and the subsequent release of acoustic energy 
with compressive and tensile stresses [18] mechanically interact with the cell membrane. 
Other studies have shown that stable bubble oscillation also works effectively [51]. 
Ultrasound has proved effective for intracellular delivery [18], [22] and can be combined 
with microbubbles to improve efficacy of delivery. Yet, there are a number of 
disadvantages associated with ultrasonic delivery methods. The effects of ultrasound 
ultimately depend on the amount of acoustic energy released, which in some cases can 
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cause excessive damage to cells and result in significant cell death. Additionally, the 
polydispersity of cavitation agents makes ultrasound makes process control very difficult.  
2.2.3.3 Microinjection 
Essentially any type of molecule can be delivered into cells with microinjection. 
Microinjection occurs when a glass needle is inserted into a cell and the molecules of 
interest are directly delivered into the cytosol [52]. This method is advantageous since there 
is direct control of the amount of therapy delivered into the cells. Still, microinjection is 
limited by its inherent mechanism – it is only optimal for single cell delivery. Physical 
injury and cell viability are also drawbacks associated with microinjection [52]. 
2.2.3.4 Laser-mediated delivery 
Engineer and physicist, Theodore Maiman developed the first working laser in 
1960 [53]. A year later, dermatologist Leon Goldman was the first to translate laser 
technology into medicine [54], [55], using a laser to treat skin melanoma. Currently, lasers 
are used in a variety of medical applications including, but not limited to dermatology, 
medical imaging, ophthalmology (e.g. LASIK) [54], surgery, and cancer treatment [54].  
Laser-mediated intracellular drug delivery can be divided into methods which 
facilitate the transfer of laser energy to the cell. The literature segments laser-mediated 
delivery into optoporation and optoinjection methods. Optoporation utilizes a focused laser 
light to induce thermal damage in cell membranes, creating disruption and then molecular 
uptake [56]. Optoinjection uses laser light to create acoustic waves or shockwaves to 
mechanically impact cells and cause disruptions in the membrane to facilitate delivery. 
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This can be achieved using laser-nanoparticle interaction [57], [58] or shockwave 
lithography from shocktubes [59]–[61] 
We can think of optoinjection methods as driven by energy transducers. That is, an 
energy absorber receives an external source of energy, converts the energy and then 
transmits it to its surroundings. A growing category of energy absorbers are nanoparticles 
for use in nanomedicine applications. Nanoparticles that can strongly absorb near infrared 
(NIR) laser energy are beneficial for clinical applications. Near-infrared lasers are used in 
the medical field because NIR light can penetrate several centimeters below the skin and 
transmit through blood and other components of complex tissue systems [62].  
2.2.4 Laser-energy absorbing nanoparticles 
2.2.4.1 Gold nanostructures  
Metallic nanoparticles, such as gold (Au) are utilized for laser-mediated 
intracellular drug delivery. Au nanoparticles are highly regarded for their properties and 
potential for nanomedicine due to their biocompatibility and inherent structural and 
chemical properties. When Au nanoparticles are irradiated at a specific wavelength of laser 
light, delocalized electrons oscillate upon exposure to electromagnetic radiation. These 
electronic oscillations phenomena, coupled with subsequent scattering and absorption is 
known as the localized surface plasmon resonance (LSPR) effect [62]. When a noble metal 
nanoparticle absorbs laser light, the particle undergoes a series of electron oscillations, and 
as a result, heat rapidly transferred to the medium and stress waves are generated [63]. 
These photothermal effects have been useful for intracellular delivery [63]. The LSPR 
response is highly dependent on the size, shape, and morphology of the gold nanoparticle 
 14 
[62]. Gold nanoparticles are useful if the surface plasmon resonance peaks are tuned to 
near-IR regions for biomedical applications (800-1200 nm) [62], [64]. 
2.2.4.2 Carbon nanoparticles 
Carbon nanoparticles have also been leveraged for laser-mediated drug delivery 
platforms. Carbon has been studied in drug delivery research, evidenced by the growing 
popularity of carbon nanotubes and fullerenes [13], [26], [35], [65]. Carbon black (CB), a 
form of elemental carbon, has been used in medical tattoos and drug delivery [13], [14], 
while activated carbon/charcoal is used for filtration systems and most recently for possible 
treatment of irritable bowel syndrome [66]. Carbon black is manufactured to have a range 
of particle sizes on the nanoscale (25-75 nm) (Figure 2.2), but their preferred 
macrostructure is in the aggregated form [67], resulting in clusters on the order of hundreds 
of nanometers. Carbon black, in contrast to Au nanostructures, does not have a preferential 
absorption band in the IR regime but has a broadband absorption that includes the near IR 




Figure 2.2: TEM image of carbon black nanoparticles with an average diameter of 28 
nm as measured by ImageJ software. Scale bar = 200 nm.  
2.2.5 Physical methods can be advantageous over chemical and biological methods 
Overall, physical methods of drug delivery can be advantageous over chemical and 
biological methods. Since physical methods exploit external forces for delivery, these 
techniques are not limited to a particular cell type or drug. Additionally, since drug 
modification is unnecessary, the active substance can be targeted directly into the cytosol, 
avoiding the need for ligands or other surface targeting moieties [38]. This direct targeting 
also enables the bypassing the possibly damaging effects of biological pathways, i.e. 
endocytosis [7]. Finally, these methods are faster compared to chemical and biological 
techniques because molecules are delivered intracellularly during active disruption of the 
cell membrane. Nevertheless, the key challenge with physical methods is to balance the 
tradeoff associated with cell viability and high drug uptake due to physical forces impacting 
the cell [38], [39]. 
2.3 Carbon black for laser-mediated drug delivery 
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Researchers have studied carbon black extensively to understand its properties and 
its behavior upon IR laser irradiation. Carbon black has been shown to strongly absorb IR 
light and release the converted energy in acoustic waves. Diebold and colleagues studied 
the production of shockwaves, chemical products [68]–[71], and the “photoacoustic effect” 
[15] associated with IR irradiation of carbon black suspensions after sustained exposures. 
The photoacoustic effect is caused by a rapid volume change due to formation of a vapor 
shell around the heated particle. This change in volume induces a carbon-steam reaction, 
where the gaseous byproducts lead to a rise in pressure [15], [70].  
Inspired by Chen and Diebold’s photoacoustic effect studies, CB was incorporated 
into a laser-mediated drug delivery system to leverage CB’s photoacoustic properties for 
disruption of membranes. From a historical context, a variety of studies were conducted in 
the Prausnitz Laboratory for Drug Delivery using ultrasound [16], [18]–[22], [44]. As 
previously mentioned, ultrasound drug delivery systems are challenging to optimize, due 
to the tradeoff between cell viability and molecular delivery. Carbon black’s photoacoustic 
effect was thought to be a better alternative to ultrasound methods, which due to violent 
cavitation events can result in more cell death than delivery of molecules [22].  
When carbon black nanoparticles in suspension with cells and small molecules 
were exposed to femtosecond-pulsed laser light resulted in high uptake and cell viability 
[13]. Chakravarty et al. [13], [72] used carbon black coupled with femtosecond and 
nanosecond laser pulses to deliver DNA, BSA (bovine serum albumin), and calcein 
(Figure 2.3) into DU145 human prostate cancer cells. It was hypothesized that the 
photoacoustic effect and the carbon-steam chemical reaction observed in Diebold’s studies 
were mechanistically responsible for intracellular delivery. Due to heating of carbon 
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nanoparticles and the surrounding liquid medium, it was hypothesized that the carbon-
steam reaction led to gaseous byproducts and bubble formation [13]. The hypothesis 
continued to posit that the subsequent collapse of these bubbles emitted acoustic waves 
[15] and mechanically interacted with the surrounding cellular membranes to create pores 
[13] and drive intracellular drug delivery. 
 
Figure 2.3: Fluorescent micrographs showing intracellular uptake of calcein at a) 10x 
magnification and b) 40x magnification, where the uptake of calcein is seen 
throughout the cell. Adapted from [13]. 
Subsequent work focused on investigating the effects of nanosecond pulsed laser 
energy. A Nd:YAG laser was an attractive alternative to the previously used Ti:Sapphire 
femtosecond laser, because of its low cost and ease of manipulation. Sengupta [14], [23] 
irradiated CB nanoparticles with a Nd:YAG nanosecond-pulsed laser to investigate the 
mechanisms and potential translational applications associated with this method. For 
example, using nanosecond-pulse laser energy with CB, siRNA was successfully delivered 
into ovarian cancer cells and led to gene knockdown [73]. Other studies showed that there 
is a delivery threshold for this method based on particle size ( < 500 kDa) [14].  
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Sengupta [23] also explored this laser-CB method mechanistically and discovered 
several important facets fundamental to this thesis. They found that the carbon-steam 
reaction was not integral to the delivery mechanism as once hypothesized. In fact, it was 
concluded that the laser irradiation of CB nanoparticles and subsequent thermal expansion 
was the physical explanation for vapor formation and the release of acoustic waves. It was 
then hypothesized that the observed bioeffects were due to acoustic and/or thermal 
mechanisms. This was explained by the greater particle radius change due to vapor bubble 
formation than for solid volume expansion [23]. This secondary hypothesis posited that the 
combined energy transduction mechanisms, phenomena hereby referred to as transient 
nanoparticle energy transduction (TNET), were responsible for the observed bioeffects of 
high viability and high drug uptake.  
Sengupta’s work provided a basis to think of CB nanoparticles acting as energy 
transducers. The energy released was assumed to take different forms. Following laser 
irradiation of CB nanoparticles, it was hypothesized that CB could possibly transmit energy 
to the cell via two length-scales -- 1) long-range, indirect, cumulative acoustic emissions 
from bubbles or 2) short-range, local cell-bubble interaction:  
(i) Long-range effects: Thermal expansion of particle leading to pressure 
disrupting the membrane 
(ii) Long-range effects: acoustics/cumulative positive peak pressure output due 
to heat transfer from the particle which results in vapor formation and then 
disrupts the membrane  
(iii) Short-range: local cell-particle / cell-bubble energy transfer 
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a. Heat transfer from physical contact of the bubble/particle to cell which 
create pores in the membrane 
b. Point of source, local fluid mechanics and/or near-field acoustics which 
mechanically disrupt the membrane 
 
Figure 2.4: Schematic describing TNET where laser irradiation of CB nanoparticles 
leads to heating, and then acoustic & thermal energy transfer from the nanoparticles. 
Adapted from [23]. 
Some of these mechanisms were explored by Sengupta and colleagues. One crucial 
study from Sengupta’s work was the acoustic characterization of carbon black 
nanoparticles. Several calculations and experiments suggested that a cell only experiences 
pressure from the nearest CB particles due to a shielding effect from a cumulative field of 
carbon nanoparticles [23]. This suggested that long-range interactions were not the 
dominant cause of TNET. Other results from this study showed that TNET was not due to 
the thermal expansion of the CB nanoparticles. Additionally, Sengupta established the 
theoretical energy transfer framework using Mie scattering theory, which enabled 
calculations of peak particle temperatures and vapor bubble size [23].  
Nevertheless, there are still many unanswered questions related to TNET 
mechanistically. More specifically, we aim to have a more detailed understanding of the 
dominant energy modes which drive TNET. Within that, it is not known how the various 
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posited energy methods (i.e. (ii) – (iii) listed above) are related to CB’s interaction with the 
cell, the role of cell mechanics in TNET, the influence of physical boundaries in vitro, and 
acoustic long- and near-field effects on the cell membrane. Hence, there is a need to further 
explore and validate the energetic mechanisms responsible for the observed bioeffects (e.g. 
highly efficient delivery) due to TNET. This dissertation seeks to addresses these questions 
and provide a more detailed, biophysical explanation for phenomena observed via transient 
nanoparticle energy transduction. 
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CHAPTER 3. ROLE OF CYTOSKELETAL MECHANICS AND 
CELL MEMBRANE FLUIDITY IN THE INTRACELLULAR 
DELIVERY OF MOLECULES MEDIATED BY LASER-
ACTIVATED CARBON NANOPARTICLES 
3.1 Introduction 
 During TNET, CB nanoparticles strongly absorb near-infrared laser energy and 
convert the energy into other forms (e.g. pressure, heat) which are transduced into the 
surrounding medium [23]. More specifically, laser irradiation is believed to heat the CB 
nanoparticles by hundreds of degrees Celsius, which causes vaporization of the 
surrounding medium to create bubbles that transfer heat and momentum (e.g. fluid flow 
and acoustic waves) to nearby cells. These thermal and mechanical stresses are believed to 
generate transient membrane pores that enable intracellular delivery of molecules as well 
as sometimes cause cell death.  
The biophysical interactions between cells and TNET energy transfer, however, are 
not fully understood. More specifically, the role of cell mechanical properties has not been 
studied. Thus, we conducted a study to determine the effects of cytoskeletal mechanics and 
plasma membrane fluidity on intracellular uptake and cell viability (i.e., bioeffects) 
associated with TNET. We hypothesize that weakening the cytoskeleton by destabilizing 
actin filaments increases intracellular uptake of molecules and reduces cell viability loss, 
whereas altering plasma membrane fluidity may increase or decrease uptake and viability 
due to TNET. 
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3.2 Methods 
3.2.1 Nanoparticle Preparation  
 CB nanoparticles were prepared as previously described [14]. In brief, CB 
nanoparticles (Black Pearls 470, Cabot, Boston, MA) were added at a concentration of 0.4 
g/L to deionized water containing 0.013% (v/v) Tween-80 (Sigma-Aldrich, St. Louis, MO) 
to enhance solution stability. The solution was sonicated for 35 min in an ultrasonic water 
bath (FS3OH, Fisher Scientific, Pittsburg, PA) and with an ultrasonic needle for 1 min 
(Sonics Ultracell, Sonics & Materials, Newton, CT). According to the manufacturer, 
individual CB nanoparticles were 25 nm in size. However, dynamic light scattering 
measurements conducted by us revealed that the nanoparticle assembled into clusters with 
an effective diameter of 201.4 ± 5.5 nm (n=10) and a dispersity of 0.15 ± 0.04 nm (n=10 
replicates) (ZetaSizer Nano, Malvern Instruments, Malvern, UK). Sonication described 
above was not able to decrease cluster size further.  
3.2.2 Laser system for in vitro exposures 
 A Nd:YAG solid-state laser (Continuum Powerlite II Plus, Continuum, San Jose, 
CA) was used to apply 5-9 ns pulses of 1064 nm wavelength at a frequency of 10 Hz (i.e. 
10 pulses per second) to cell suspensions. Pulse fluence was varied by changing the 
amplifier voltage settings of the laser. The initial Super-Gaussian 12 mm wide beam was 
passed through an 8 mm aperture to create a pseudo-flat top profile to achieve a more 
homogeneous distribution of the laser energy. The 8 mm beam was then passed through a 
diverging lens (f =50 cm) (ThorLabs, Newton, NJ) to illuminate the entire exposure area 
of the cuvette (4 cm2). 
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3.2.2.1 Laser beam characterization 
A laser beam profiler (LaserCam HR 1098577, Coherent, Santa Clara, CA) was 
used to characterize the 12 mm super-Gaussian beam emitted from the Nd:YAG laser 
(Continuum Powerlite II Plus, Continuum, San Jose, CA) prior to and following its 
propagation through an 8 mm aperture. Several neutral density filters were used to prevent 
saturation of the signal and damage to the LaserCam HR. The pseudo-flat top beam profile 
showed a more homogenous distribution of energy compared to the super-Gaussian beam 
(Figure 3.1). 
        
Figure 3.1: Beam profiles of a) super-Gaussian beam and b) pseudo-flat top beam 
captured with the LaserCam HR. The false color scale bar (left of the profiles) is a 
qualitative measure of intensity, where the color at the top of the bar is the maximum 
intensity (BeamView USB 4.8.1 software). The laser beam was focused down using a 
biconvex lens due to the LaserCam HR camera’s 6 mm diameter. Scale bar = 3 mm. 
3.2.3 Altering cytoskeleton via actin manipulation 
 To alter the cytoskeleton’s mechanical properties, latrunculin A (LatA) was used 
to inhibit actin polymerization and dissemble actin filaments [74]–[76] and jasplakinolide 
(Jasplak) was used to promote actin polymerization, thereby reinforcing and rigidifying 
actin filaments in the cytoskeleton [77]. LatA (Sigma-Aldrich) was dissolved in ethanol at 
a b 
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a stock concentration of 75 µM and Jasplak (Cayman Chemicals, Ann Arbor, MI) was also 
dissolved in ethanol at a stock concentration of 10 µM.  
3.2.3.1 Assay to measure actin destabilization 
A high throughput assay leveraging flow cytometry was developed to quantify actin 
content via fluorescence of phalloidin. In brief, DU145 cells were incubated with 
latrunculin A (LatA) for 30 – 60 min at 37ºC. Then, cells were fixed with 4% 
paraformaldehyde at room temperature and permeated with 0.1% Triton X-100 (Sigma-
Aldrich, St. Louis, MO) for staining with fluorescently labeled Alexa Fluor 488–phalloidin 
(ThermoFisher Scientific, Waltham, MA). Alexa Fluor 488–phalloidin was used to 
quantify actin fluorescence after DU145 cells were treated with 0.1, 0.3, 0.5, 1, and 5 µM 
LatA. Histograms from a BD Accuri C6 flow cytometer (Becton Dickinson, Franklin 
Lakes, NJ) show a significant decrease in the FL1-A signal (FITC channel) with increasing 
LatA (Figure 3.2). 
 
Figure 3.2: Histogram displaying relative Alexa Fluor 488 phalloidin fluorescence for 
non-treated cells and cells treated with 0.5 and 1 µM LatA. 
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The total fluorescence signal from the FITC channel for samples were analyzed to 
compare relative fluorescence. Cells treated with LatA were normalized to cells without 
LatA treatment, but stained with Alexa Fluor 488–phalloidin to quantify the initial actin 
fluorescence in DU145 cells (Figure 3.3). Latrunculin A’s effect of decreasing actin 
fluorescence was consistent with other studies in literature [74], [75], [78]. 













































































Figure 3.3: Normalized phalloidin fluorescence for DU145 cells stained with Alexa 
Fluor 488–phalloidin. a) Cells treated with 0.1 µM LatA and 0.3 µM LatA and 
incubated for 60 min at 37ºC. b) Cells treated with 0.5 µM, 1 µM and 5 µM LatA and 
incubated for 30 min at 37 ºC. Data show mean and SD (n≥3). 
3.2.4 Altering cholesterol content of plasma membrane 
Cholesterol content of the plasma membrane was decreased using methyl-β-
cyclodextran (MβCD; Sigma-Aldrich) [79] and increased using water-soluble cholesterol 
(WSC; Sigma-Aldrich). MβCD was prepared in deionized water at a stock solution of 38 
mM and WSC was also prepared in deionized water at a stock concentration of 200 mM 
[76]. 
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3.2.4.1 Assays to confirm cholesterol depletion or enrichment with cholesterol-based 
reagents 
An Amplex-Red cholesterol oxidase assay (ThermoFisher Scientific, Waltham, 
MA) was used to quantify total cholesterol content for cells treated with MβCD and WSC. 
DU145 cells were incubated with 200 µM, 1mM and 10 mM MβCD, and 0.1 mM, 1 mM 
and 5 mM WSC. Cells were seeded at 2500 cells/well in 100 µL onto a black 96 well tissue-
cultured treated plate for 24 hours. The fluorescence intensity was measured with a 
spectrophotometer (Synergy H4, BioTek, Winooski, VT) after one hour of incubation at 
37ºC, with excitation and emission peaks at 530 nm (±25) and 590 nm (±35), respectively. 
MβCD decreased the total cholesterol content compared to non-treated cells (Figure 3.4a), 
whereas WSC increased cholesterol content compared to non-treated cells (Figure 3.4b). 
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Figure 3.4: Total cholesterol content (µM) for ~2.5 x 103 DU145 cells treated with a) 
MβCD and b) WSC following 1 hour of incubation at 37ºC. The total cholesterol 
content is the summation of cholesteryl esters plus free cholesterol detected by the 
cholesterol oxidase assay. Data show mean and SD (n ≥ 3). 
3.2.5 Cell culture and in vitro experiments 
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 Human prostate cancer cells (DU145, American Type Culture Collection, 
Manassas, VA) were cultured as monolayers in a humidified atmosphere of 95% air and 
5% CO2 at 37°C in RPMI-1640 medium (Cellgro, Herndon, VA) supplemented with 100 
g/mL penicillin-streptomycin (Cellgro) and 10% (v/v) heat inactivated fetal bovine serum 
(FBS) (Corning, Palo Alto, CA). Cells were harvested at 80-90% confluence for 
experiments by trypsin/EDTA (Cellgro) digestion, washed with serum and then re-
suspended in RPMI at a cell concentration of 106 cells/mL. DU145 cells were used as the 
model cell line for these experiments because these cells have been widely used and 
characterized in previous drug delivery studies [13], [14], [20].  
 Harvested cells were mixed with carbon nanoparticles at a final concentration of 25 
mg/L and high-purity calcein (Molecular Probes, Eugene, OR) as an uptake marker at a 
final concentration of 10 μM, and kept in 1.5 mL microcentrifuge tubes on ice. In some 
cases, reagents for cytoskeleton and cell membrane manipulation were added and 
incubated at 37º C for 1 h before laser exposure. Then, 520 μL of the cell suspension was 
transferred to Pyrex glass cuvettes (37-PX-2, Starna Cells, Atascadero, CA) for laser 
exposure. Negative controls in the form of ‘sham’ exposures were samples containing cells, 
CB nanoparticles, and calcein that experienced the same handling and procedures except 
the laser exposure.  
 Following laser exposure, the cuvette contents were transferred back into the 
microcentrifuge tubes with a transfer pipette and stored on ice to reduce uptake due to 
endocytosis. To label nonviable, necrotic cells post-irradiation, propidium iodide 
(Invitrogen, Grand Island, NY) was added at a final concentration of 13.4 μM for 10 min 
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on ice. Samples were washed at least 3 times with phosphate buffer saline (PBS) to remove 
excess fluorescence from the bulk solution before analysis by flow cytometry. 
3.2.6 Data collection & processing 
 A bench-top flow cytometer (BD Accuri, BD Biosciences, San Jose, CA) quantified 
bioeffects in terms of live cells with intracellular uptake (i.e. intact cells with green 
fluorescence of calcein loading and without red fluorescence of propidium iodide staining) 
and non-viable cells (i.e. intact cells with propidium iodide staining). Calcein fluorescence 
was measured using 530/28 nm bandpass filter with excitation at 488 nm and propidium 
iodide fluorescence was measured using a 670 nm longpass filter with a maximum 
excitation at 535 nm.  
 Samples were run at a constant flow rate of 35 μL/min for 1 min. A negative control 
containing only cells in RPMI was used to construct a cell population gate in the forward-
scattered and side-scattered analysis. Cells within this gate were considered to be intact 
cells. To account for possible cell loss due to cell fragmentation (appearing as low forward 
scatter and low side scatter events on the flow cytometer), the difference between the 
number of viable cells (i.e., not stained by propidium iodide) detected in a given sample 
compared to viable cells detected in sham samples was taken to equal the number of cells 
lost to fragmentation [80]. 
3.2.7 Statistical analysis  
 A minimum of three replicates was used for all conditions, which enabled 
calculation of means and standard deviations. The null hypothesis was that the average 
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fraction of cells with uptake or viability in a sham sample and an exposed sample were 
equal. The equality of means response between exposed samples and sham samples was 
tested with ANOVA (α = 0.05). The equality of means response was tested with 1-way or 
2-way ANOVA followed by post-hoc Tukey’s pairwise comparison using GraphPad Prism 
6 (GraphPad Software, La Jolla, CA).  
3.3 Results 
3.3.1 Evaluating role of cytoskeleton by actin manipulation with latrunculin A and 
jasplakinolide 
We exposed cells to different concentrations of LatA to decrease the actin content 
in the cytoskeleton using established methods [74], [78] and verified actin content 
reduction using an established phalloidin fluorescence assay [81] (Figure 3.2, Figure 3.3). 
After completing this validation, cells with and without LatA treatment at different 
concentrations were exposed to laser pulses over a range of fluence values to determine the 
effect of cytoskeletal weakening on intracellular uptake of molecules and cell viability 
(Figure 3.).  
 At low LatA concentration (0.1 µM), mild cytoskeletal weakening had a protective 
effect that enabled higher intracellular uptake of molecules (Figure 3.a(i)) and less loss of 
cell viability (Figure 3.b(i)) at moderate laser fluence. However, this treatment did not 
have an effect at higher laser fluence where perhaps mild cytoskeletal weakening could not 
protect against strong TNET forces. In this analysis, intracellular uptake of molecules is 
expressed as the percent of cells exhibiting uptake of the small molecule fluorescent 
marker, calcein (623 Da molecular weight). Loss of cell viability is expressed as the percent 
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of cells either identified as non-viable due to staining with propidium iodide or identified 





Figure 3.5: Percentage of latrunculin-A (LatA)-treated and non-treated cells with a) 
intracellular uptake, b) viability loss and c) (continued on next page) total bioeffects 
(uptake and viability loss) after 1 minute of pulsed exposure to laser fluence ranging 
from 19 - 88 mJ/cm2. Non-viable cells are subdivided into those staining positive for 
propidium iodide (PI+) and those determined to be fragmented. Cells were treated 
with i) 0.1 µM LatA, ii) 0.3 µM LatA, iii) 1 µM LatA, and iv) 5 µM LatA. Asterisks 
(*) indicate bioeffect was significantly lower in samples with LatA treatment versus 
companion samples without LatA treatment (ANOVA, * p < 0.05, ** p < 0.01, *** p 
< 0.001, **** p < 0.0001). Pound (#) indicates bioeffect was significantly higher in 
samples with LatA treatment versus companion samples without LatA treatment 
(ANOVA, # p < 0.05, ## p < 0.01, ### p < 0.001, #### p < 0.0001). Data show average 




Figure 3.5 (continued): Percentage of latrunculin-A (LatA)-treated and non-treated 
cells with a) intracellular uptake, b) viability loss and c) total bioeffects (uptake and 
viability loss) after 1 minute of pulsed exposure to laser fluence ranging from 19 - 88 
mJ/cm2. Non-viable cells are subdivided into those staining positive for propidium 
iodide (PI+) and those determined to be fragmented. Cells were treated with i) 0.1 µM 
LatA, ii) 0.3 µM LatA, iii) 1 µM LatA, and iv) 5 µM LatA. Asterisks (*) indicate 
bioeffect was significantly lower in samples with LatA treatment versus companion 
samples without LatA treatment (ANOVA, * p < 0.05, ** p < 0.01, *** p < 0.001, **** 
p < 0.0001). Pound (#) indicates bioeffect was significantly higher in samples with 
LatA treatment versus companion samples without LatA treatment (ANOVA, # p < 
0.05, ## p < 0.01, ### p < 0.001, #### p < 0.0001). Data show average ± SD (n=3). 
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At higher LatA concentration (0.3 µM, 1 µM), the increased level of cytoskeletal 
weakening had a protective effect that enabled higher intracellular uptake (Figure 3.a(ii) 
and Figure 3.a(iii)) and less cell viability loss (Figure 3.b(ii) and Figure 3.b(iii)) at both 
moderate and high laser fluence. However, at low laser fluence, treatment with 1 µM LatA 
had a negative effect on cells, causing lower uptake (Figure 3.a(iii)) and more viability 
loss (even among sham-exposed cells, Figure 3.b(iii)), suggesting that the toxic effects of 
a higher concentration of LatA outweighed its protective effects under mild TNET 
conditions. LatA concentrations above 0.5 µM are known to cause severe cytoskeletal 
weakening that can affect cell viability [74], [77].  
Finally, at the highest LatA concentration (5 µM), the toxic effects of LatA were 
even more evident, where the high level of cytoskeletal weakening caused less uptake 
(Figure 3.a(iv)) and more viability loss (again, even among sham-exposed cells, Figure 
3.b(iv)) and provided no protective effect at higher laser fluence.  
Considering the total bioeffects – i.e., all cells exhibiting either intracellular uptake 
or loss of viability – we see that overall (with a few exceptions) there is no significant 
difference in the total fraction of cells affected by laser exposure with versus without LatA 
treatment (Figure 3.5Figure 3.c). This suggests that LatA does not primarily affect the 
initial impact of TNET on cells, but rather affects the cells’ ability to recover from that 
impact. We propose that cells with intact cytoskeletons that are permeabilized by TNET 
may be more likely to become non-viable afterwards due to an inability to recover from 
the transient damage done by TNET (i.e., what would have been uptake cells become 
nonviable cells). In contrast, we propose that cells with weakened cytoskeletons are better 
able to recover from TNET exposures, thereby keeping permeabilized cells viable (i.e., 
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uptake cells remain viable). This interpretation is further supported by the observation that 
there are similar and low levels of fragmented cells among LatA-exposed and non-exposed 
cells, other than at the highest LatA concentration where LatA toxicity appears to become 
an important factor. Cell fragmentation is believed to occur at the time of TNET impact on 
cells, whereas nonviable cells identified by propidium iodide staining are believed to be 
cells that became nonviable due to stresses after TNET exposure. These interpretations 
require additional study and further validation.  
Given the dramatic effects of cytoskeletal weakening by LatA, we next studied the 
effects of exposure of cells to Jasplak, which increases actin polymerization and rigidifies 
existing filaments, thereby strengthening the cytoskeleton [77], [82]. We used a single 
concentration of 0.5 µM Jasplak, based on prior literature [74], [77]. Intracellular uptake 
was generally unaffected by exposure to Jasplak, other than at 44 mJ/cm2, where uptake 
was higher (Figure 3.6a). Cell viability loss (Figure 3.6b) and total cells with bioeffects 
(Figure 3.6c) were unaffected at all conditions studied. It is interesting to note, however, 
that the percentage of fragmented cells was significantly less among cells exposed to 
Jasplak (ANOVA, p < 0.001), suggesting that strengthening the cytoskeleton inhibited cell 




Figure 3.6: Percentage of Jasplakinolide (Jasplak)-treated and non-treated cells with 
a) intracellular uptake, b) viability loss and c) (continued on next page) total bioeffects 
(uptake and viability loss) after 1 minute of exposure to laser fluence of 44, 63, and 88 
mJ/cm2. Non-viable cells are subdivided into those staining positive for propidium 
iodide (PI+) and those determined to be fragmented. Asterisks (**) indicate bioeffect 
was significantly higher in samples with Jasplak treatment versus companion samples 





Figure 3.6 (continued): Percentage of Jasplakinolide (Jasplak)-treated and non-
treated cells with a) intracellular uptake, b) viability loss and c) total bioeffects 
(uptake and viability loss) after 1 minute of exposure to laser fluence of 44, 63, and 88 
mJ/cm2. Non-viable cells are subdivided into those staining positive for propidium 
iodide (PI+) and those determined to be fragmented. Asterisks (**) indicate bioeffect 
was significantly higher in samples with Jasplak treatment versus companion samples 
without Jasplak treatment (ANOVA, ** p < 0.01). Data show mean ± SD (n=3). 
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3.3.2 Evaluating role of plasma membrane fluidity with methyl-β-cyclodextrin and 
water-soluble cholesterol 
 Cholesterol helps to regulate the overall fluidity of the cell membrane [83], [84]. 
Exposure of cells to MβCD can increase cell membrane fluidity by depleting cholesterol 
from the cell membrane [85]–[87], whereas WSC can enrich the membrane with 
cholesterol and thereby decrease membrane fluidity [88], [89]. We validated these methods 
of altering cholesterol content in cell membranes (Figure 3.4). 
 To determine if increased cell membrane fluidity affected cellular bioeffects of 
TNET, we treated cells treated with two different concentrations of MβCD and found that 
there were no significant differences in uptake, viability loss (including cell fragmentation) 
or total bioeffects at all laser fluence values, with only one exception (Figure 3.7a-c). We 
therefore conclude that increased membrane fluidity due to MβCD exposure did not 
significantly influence bioeffects caused by TNET under the conditions studied.  
 To decrease membrane fluidity, cells were treated with WSC at three different 
concentrations and then exposed to TNET using a range of laser fluence values. In general, 
cells treated with WSC showed similar uptake, viability loss (including cell fragmentation) 
and total bioeffects at all conditions studied, with only a few exceptions (Figure 3.8). We 
therefore conclude that decreased membrane fluidity due to WSC exposure had little or no 





Figure 3.7: Percentage of methyl-β-cyclodextran (MβCD)-treated and non-treated 
cells with a) intracellular uptake, b) viability loss and c) (continued on next page) total 
bioeffects (uptake and viability loss) after exposure for 1 minute to laser fluence 
ranging from 19 – 88 mJ/cm2. Non-viable cells are subdivided into those staining 
positive for propidium iodide (PI+) and those determined to be fragmented. Cells 
were treated with i) 200 µM MβCD and ii) 5 mM MβCD. ‘n.d’ signifies no data for 
that condition. Pound (#) indicates bioeffect was significantly lower in samples with 
MβCD treatment versus companion samples without MβCD treatment (ANOVA, p < 




Figure 3.7 (continued): Percentage of methyl-β-cyclodextran (MβCD)-treated and 
non-treated cells with a) intracellular uptake, b) viability loss and c) total bioeffects 
(uptake and viability loss) after exposure for 1 minute to laser fluence ranging from 
19 – 88 mJ/cm2. Non-viable cells are subdivided into those staining positive for 
propidium iodide (PI+) and those determined to be fragmented. Cells were treated 
with i) 200 µM MβCD and ii) 5 mM MβCD. ‘n.d’ signifies no data for that condition. 
Pound (#) indicates bioeffect was significantly lower in samples with MβCD treatment 
versus companion samples without MβCD treatment (ANOVA, p < 0.001). Data show 
mean ± SD (n=3). 
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Figure 3.8: Percentage of water-soluble cholesterol (WSC)-treated and non-treated 
cells with a) intracellular uptake, b) viability loss and c) (continued on next page) total 
bioeffects (uptake and viability loss) after exposure for 1 minute to laser fluence 
ranging from 19 - 88 mJ/cm2. Non-viable cells are subdivided into those staining 
positive for propidium iodide (PI+) and those determined to be fragmented. Cells 
were treated with i) 0.1 mM WSC, ii) 1 mM WSC, and iii) 5 mM WSC. Asterisks (*) 
indicate bioeffect was significantly higher in samples with WSC treatment versus 
companion samples without WSC treatment (ANOVA, ** p < 0.01, *** p < 0.001). 
Pound (#) indicates bioeffect was significantly lower in samples with WSC treatment 
versus companion samples without WSC treatment (ANOVA, ## p < 0.01). Data show 




Figure 3.8 (continued): Percentage of water-soluble cholesterol (WSC)-treated and 
non-treated cells with a) intracellular uptake, b) viability loss and c) total bioeffects 
(uptake and viability loss) after exposure for 1 minute to laser fluence ranging from 
19 - 88 mJ/cm2. Non-viable cells are subdivided into those staining positive for 
propidium iodide (PI+) and those determined to be fragmented. Cells were treated 
with i) 0.1 mM WSC, ii) 1 mM WSC, and iii) 5 mM WSC. Asterisks (*) indicate 
bioeffect was significantly higher in samples with WSC treatment versus companion 
samples without WSC treatment (ANOVA, ** p < 0.01, *** p < 0.001). Pound (#) 
indicates bioeffect was significantly lower in samples with WSC treatment versus 
companion samples without WSC treatment (ANOVA, ## p < 0.01). Data show mean 




 The goal of this investigation was to study the influence of cytoskeletal mechanics 
and the fluidity of the plasma membrane on bioeffects observed with TNET. We 
hypothesized that weakening cytoskeleton by destabilizing actin filaments increases 
intracellular uptake of molecules and reduces cell viability loss, whereas altering plasma 
membrane fluidity has could increase or decrease uptake or viability due to TNET. The 
results from this study support the former hypothesis, however our fluidity studies showed 
that there is no significant effect on bioeffects.  
3.4.1 Weakening cytoskeletal mechanical properties increased intracellular uptake and 
reduced viability loss 
 It is notable that intracellular uptake was increased and viability loss was reduced 
by cytoskeletal weakening via treatment of cells with LatA (Figure 3.5). This finding can 
provide mechanistic insight into TNET’s effects on cells and suggest strategies to increase 
intracellular delivery of molecules into viable cells, which is a desirable outcome for 
laboratory and possible future medical applications.   
 The cytoskeleton provides mechanical and spatial support to the cell and more 
specifically supports the plasma membrane [90]. Mechanical stresses imparted on a 
eukaryotic cell are distributed by the cytoskeleton [91], [92], which consists of a 
biopolymer network of proteins, including actin filaments, microtubules, and intermediate 
filaments. Actin filaments provide elastic support for the cell, and dynamically assemble 
and disassemble in response to local stress perturbations to maintain entropic stability [91].  
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3.4.1.1 Hypothesis #1 
 We hypothesize that TNET results in a mechanical impact on cells due to an 
acoustic pressure pulse and/or fluid motion caused by rapidly expanding vapor bubbles 
surrounding the CB nanoparticle [23]. Weakening the cytoskeleton could alter this 
mechanical interaction by making the cell more susceptible to deformation and thereby 
altering the nature of the cell membrane permeabilization that occurs. This change could 
result in greater and/or longer-lasting permeabilization of the membrane leading to 
increased intracellular uptake. Other studies demonstrated that LatA disrupts the actin 
network and can reduce the average Young’s modulus by a factor of 3, leading to a 
significant reduction in the cell’s mechanical strength [74].  
3.4.1.2 Hypothesis #2 
 Our first hypothesis does not appear to be sufficient to explain the reduced cell 
viability loss that was also observed. Another explanation is that the changed interaction 
between the mechanical forces of TNET and a structurally weakened cell enable 
permeabilized cells to recover and retain viability more effectively. We hypothesize that 
some cells permeabilized by TNET can recover from that intervention and thereby be 
classified as cells with uptake, and that other cells do not recover and are therefore 
classified as non-viable. It may be that the nature of the permeabilization caused by TNET 
in cells with weakened cytoskeleton allows them to more easily recover, thereby yielding 
a greater fraction of cells that remain viable and are therefore classified as cells with uptake. 
This interpretation is further supported by the observation that the total fraction of cells 
affected by TNET was independent of treatment with LatA (Figure 3.5c). It appears that 
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cytoskeletal weakening shifted cells from the non-viable classification to the intracellular 
uptake classification by helping preserve cell viability. 
3.4.1.3 Hypothesis #3 
 There is a third hypothesis that we propose, which is that weakening cytoskeleton 
has no significant effect at the time of mechanical force impact generated by TNET, i.e., 
the degree and nature of cell membrane permeabilization does not significantly depend on 
cytoskeletal weakening, at least under the conditions of this study. Instead, alterations to 
the cytoskeleton by LatA treatment affect the ability of cells to repair and recover from the 
transient permeabilization that occurred. It is known from the literature that membrane 
breaches are generated in cells due to direct application of mechanical forces and the 
process of repairing these membrane breaches involves transient tethering of the plasma 
membrane to the underlying cytoskeleton. This would suggest that TNET is a mechanical 
mechanism being that higher viability was obtained after LatA treatment. The cytoskeleton 
can act as a physical obstacle for the ‘docking’ of microvesicles needed for membrane 
fusion [93], [94]. In this way, destabilizing actin filaments can enhance membrane 
resealing [94], [95]. Thus, the effects of LatA on the cytoskeleton may facilitate cell 
membrane repair and/or other intracellular recovery processes that help cells maintain 
viability.  
3.4.2 Strengthening cytoskeletal mechanical properties did not affect intracellular 
uptake or cell viability 
 We expected that a rigidified cytoskeleton after treatment with Jasplak would result 
in less intracellular uptake compared to non-treated cells. Despite that expectation, uptake 
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and viability loss among Jasplak-treated cells were similar to non-treated cells (Figure 
3.6). In data not shown, higher Jasplak concentration (i.e., 1 µM) to rigidify actin filaments 
further [96] was toxic to cells (i.e., even without TNET in ‘sham’ cells) and resulted in a 
substantial increase in viability loss prior to laser exposure. Therefore, we tested the highest 
amount of cytoskeletal rigidification possible with Jaspak in our cells under the conditions 
studied.  
 The literature presents conflicting results regarding Jasplak’s effects. Some studies 
indicate that Jasplak stabilizes actin filaments and rigidifies the cytoskeleton [77], [97], 
[98], while others have shown that Jasplak can sometimes destabilize actin [74], [99], 
[100]. The disparities in Jasplak’s effects appear to be dependent on the cell type and 
concentration of Jasplak. These contradictory studies may explain the lack of effect of 
Jasplak on cellular bioeffects in our study. 
3.4.3 Plasma membrane fluidity did not affect intracellular uptake or cell viability 
 Cholesterol is critical to the dynamic stability and fluidity of the plasma membrane 
[83], [84], [101]. To evaluate the effect of membrane fluidity in TNET, we used MβCD to 
increase the fluidity of the membrane and WSC to decrease the fluidity of the membrane. 
Overall, cells treated with these plasma membrane fluidity-altering compounds showed no 
significant difference in intracellular uptake or viability loss compared to non-treated cells 
(Figure 3.7 and Figure 3.8). 
 Previous studies have shown that the addition of MβCD and WSC not only 
influences lipid bilayer stiffness [102] but also can affect cellular mechanotransduction 
properties [89]. Interestingly, some studies have shown that MβCD can lead to cell 
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stiffening, while WSC can increase cell elasticity [76], [101], [103]. Other investigations 
argue that these effects are cell-type dependent and are not strongly coupled [102]. These 
observations illustrate the complexity of analyzing our data. Nevertheless, our data did not 
suggest any significant effect of treatment with MβCD and WSC on intracellular uptake or 
viability, which supports the interpretation that cell membrane fluidity does not play a 
significant role in uptake and viability in TNET. This data suggests that a thermal 
mechanism in TNET is not dominant. Other laser-mediated techniques have shown that a 
thermal mechanism via local heat can increase membrane permeability [104]. However, 
without a direct assay of possible lipid phase transitions a thermal mechanism cannot be 
definitively ruled out.  
3.5 Conclusion 
 In this study, we investigated the role of cytoskeletal mechanics and plasma 
membrane fluidity on resulting bioeffects from TNET. We showed that destabilizing actin 
in the cytoskeleton using Latrunculin A led to greater intracellular uptake and less cell 
viability loss compared to non-treated cells. This suggested that the cytoskeletal effects of 
LatA may facilitate cell membrane permeabilization caused by TNET that allows greater 
uptake of molecules. It also suggested that LatA may affect the cytoskeleton in ways that 
enable cells to more easily recover from the effects TNET We also demonstrated that 
rigidifying the cytoskeleton with Jasplakinolide had no significant effect on uptake and 
viability, and found that plasma membrane fluidity did not play a significant role in 
bioeffects of TNET because neither treatment with MβCD to increase membrane fluidity 
nor treatment with WCS to decrease membrane fluidity significantly altered uptake or cell 
viability. We conclude that TNET offers a novel approach to loading molecules into cells 
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and that cytoskeletal weakening can increase intracellular uptake while reducing loss of 
cell viability.  
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CHAPTER 4. EFFECT OF LASER FLUENCE, 
NANOPARTICLE CONCENTRATION AND TOTAL 
ENERGY INPUT PER CELL ON PHOTOPORATION OF 
CELLS 
4.1 Introduction 
During TNET, CB nanoparticles strongly absorb NIR laser energy and are heated 
to temperatures that can exceed 1000ºC within nanoseconds. This thermal energy is then 
transferred to the surrounding aqueous medium, which vaporizes water and generates gas 
bubbles that grow on a time scale on the order of 100 ns and achieve a radius of up to 1 µm 
[23]. The sudden growth of the bubble emits acoustic waves and generates local fluid flow 
that can impart mechanical stresses to neighboring cells. Heat transfer to cells from hot 
bubbles also occurs. By mechanisms that are not yet fully understood, these mechanical 
and thermal stresses lead to photoporation. Photoporation, which leverages pulsed laser 
light to induce membrane poration [105], is believed to involve the creation of transient 
pores in cell membranes through which extracellular molecules can access the cytosol.  
Many parameters are expected affect the efficiency of photoporation by TNET. 
Increasing laser fluence, and number of laser pulses directly increases cumulative energy 
input into the system. Increasing CB nanoparticle concentration should also increase the 
energy input, because more nanoparticles should absorb more laser energy. Increasing cell 
concentration may not affect energy input, but could affect photoporation because the 
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cumulative energy input is divided up among more cells. Very high CB nanoparticle or cell 
concentration could reduce cumulative energy input due to laser light scattering and 
shielding/shadowing of CB nanoparticles. However, the effects of many of these 
parameters have not been studied in detail before.  
The purpose of this work was to evaluate the effects of laser fluence, laser pulse 
length, CB nanoparticle concentration and cell concentration on cellular bioeffects, i.e., 
intracellular uptake, loss of cell viability and cell fragmentation. We hypothesize that the 
effects of these four different parameters on photoporation can be explained by the 
cumulative energy input per cell that they generate, which we predict determines the 
resulting bioeffects.  
4.2 Methods 
4.2.1 Nanoparticle preparation 
 As previously described [14], CB nanoparticles (Black Pearls 470, Cabot, Boston, 
MA) were added to deionized water and 0.013% (v/v) Tween-80 (Sigma-Aldrich, St. 
Louis, MO) to make a stock concentration of 0.4 g/L. The solution was sonicated for 35 
min in an ultrasonic water bath, followed by further mixing using an ultrasonic needle for 
1 min (Sonics Ultracell, Sonics & Materials, Newton, CT). According to the manufacturer, 
CB nanoparticles had a primary particle size of 25 nm, but even after ultrasound treatment 
described above, the particles were aggregates measuring 201 ± 6 nm in size with a 
dispersity of 0.15 ± 0.04 nm (n=10), as determined by dynamic light scattering 
(ZetaSizerNano, Malvern Instruments, Lavern, Worcestershire, UK). In some cases, CB 
nanoparticle solutions were further diluted with deionized water. 
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4.2.2 Laser system for in vitro exposures 
 A Nd:YAG solid-state laser (Powerlite II Plus, Continuum, San Jose, CA) was used 
to apply pulses of 1064 nm wavelength with 5-9 ns pulse length to cell samples. The pulses 
were applied at a frequency of 10 Hz (i.e., 10 pulses per second). Laser pulse energy was 
varied by changing the amplifier voltage settings. The initial 12 mm beam from the laser 
was passed through an 8 mm aperture and then through a diverging lens (f = 50 cm) 
(ThorLabs, Newton, NJ) to illuminate the entire exposure area of the Pyrex cuvette (4 cm2). 
4.2.3 Cell culture and laser exposure experiments 
 Human prostate cancer cells (DU145, American Type Culture Collection, Manassas, 
VA) were cultured as monolayers in a humidified atmosphere of 95% air and 5% CO2 at 
37°C in RPMI-1640 medium (Cellgro, Herndon, VA) supplemented with 100 g/mL 
penicillin-streptomycin (Cellgro) and 10% (v/v) heat inactivated fetal bovine serum 
(Corning, Palo Alto, CA). Cells were harvested for experiments at 80% confluence by 
trypsin/EDTA (Cellgro) digestion, washed with serum and then re-suspended in RPMI. 
DU145 cells were used in this study because they have been extensively used and 
characterized in previous intracellular delivery studies as a model mammalian cell [13], 
[14], [20].  
 Harvested cells were stored in 1.5 mL microcentrifuge tubes on ice and then 
transferred to Pyrex glass cuvettes (37-PX-2, Starna Cells, Atascadero, CA) for laser 
exposure. Exposed cuvettes contained 520 μL of cells suspended, CB nanoparticles at 
specified concentrations and 10 μM. high-purity calcein (Molecular Probes, Eugene, OR). 
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‘Sham’ samples contained cells, CB nanoparticles, and calcein that underwent the same 
experimental conditions except without laser exposure.  
 Following laser exposure, samples were transferred back into the microcentrifuge 
tubes with a transfer pipette and stored on ice to reduce uptake due to endocytosis until all 
samples were exposed (i.e., up to 30 min). To label non-viable cells post-exposure, 
propidium iodide (PI; Invitrogen, Grand Island, NY) was added at a concentration of 13.4 
μM and incubated with cells for 10 min to stain non-viable cells. Samples were washed at 
least 3 times to remove excess fluorescence from the bulk solution before analysis by flow 
cytometry. 
4.2.4 Viscosity experiments 
 Carboxyl methylcellulose (CMC; 90 kDa, low-viscosity, Sigma Aldrich, St. Louis, 
MO) was added to some cell samples to increase viscosity. CMC was added to RPMI and 
placed in an ultrasonic water bath for 1 h before addition to cell samples at a final 
concentration of 2% CMC. The viscosities of the solution with and without 2% CMC were 
determined to be 16.9 ± 0.6 cP and 1.30 ± 0.02 cP, respectively, using a viscometer at 25ºC 
(Brookfield DV2T, Brookfield AMETEK, Middleboro, MA). 
4.2.5 Data collection and processing 
 A bench-top flow cytometer (BD Accuri, BD Biosciences, San Jose, CA) quantified 
bioeffects in terms of viable cells with intracellular uptake of calcein (i.e, percentage of 
cells with intracellular calcein and lacking PI staining), non-viable cells (i.e., percentage of 
intact cells with PI staining) and fragmented cells (see below). Calcein uptake was 
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measured by green fluorescence of cells (530/28 nm bandpass filter) and loss of cell 
viability was measured by red fluorescence of PI (670 nm longpass filter). 
 Samples were run at a constant flow rate of 35 μL/min for 1 min. A ‘cells-only’ 
negative control was used to construct a cell population gate based on forward-scatter and 
side-scatter intensities. Cells within this gate were considered intact cells. To account for 
possible cell loss due to cell fragmentation (appearing as a field of very low forward- and 
side-scattering events on the flow cytometer), the number of PI-negative cells collected 
from a given sample was subtracted from the number of PI-negative cells in ‘sham’ 
negative control samples. Next, this difference was subtracted from the number of PI-
positive cells and that result was taken to be the number of cells that were lost due to cell 
fragmentation [80]. 
4.2.6 Statistical Analysis 
 A minimum of three replicates was used for all conditions which enabled 
calculation of means and standard deviations. The null hypothesis was that the average 
percentage of cells exhibiting uptake, viability loss or fragmentation between a sham 
sample and an exposed sample were equal. The equality of means response between 
exposed samples and sham samples was tested with (α = 0.05). The equality of mean 
response was tested with 1-way or 2-way, followed by post hoc Tukey’s pairwise 
comparison using GraphPad Prism 6 (GraphPad Software, La Jolla, CA). 
4.3 Results and Discussion 
4.3.1 Effects of CB nanoparticle concentration 
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 Previous studies with laser-activated CB nanoparticles showed differences in 
bioeffects (i.e. uptake and viability loss) when the nanoparticle concentration was altered 
[23], [72]. To study the effect of energy input via CB nanoparticles, we surveyed a 
comprehensive range of nanoparticle concentrations (i.e. 0.05 mg/L to 157 mg/L) in vitro 
and quantified the resulting bioeffects with increasing laser fluence (Figure 4.1). At low 
CB nanoparticle concentrations (i.e. ≤ 0.39 mg/L), exposed cells showed minimal uptake, 
almost no viability loss and no fragmentation (Figure 4.1a-c). At intermediate 
concentrations (i.e. 3.1 – 10 mg/L), uptake increased significantly and then plateaued, 
viability loss was minimal and no significant fragmentation occurred (Figure 4.1d-f). At 
higher concentrations (i.e. 15 – 20 mg/L), uptake also plateaued with increasing laser 
fluence and fragmentation was minimal, but non-viable cells increased and plateaued with 
increasing laser fluence (Figure 4.1g-h). At even higher concentrations (i.e. 25 – 157 
mg/L), uptake peaked and then decreased, non-viable cells peaked and decreased and 
fragmentation increased significantly for 100 and 157 mg/L (Figure 4.1i-k). Overall, as 
CB nanoparticle concentration increased, cellular bioeffects became increasingly stronger.   
  
 54 





















0 .0 5  m g /L
a
U p ta k e
P I+
F ra g m
T o ta l b io e f fe c ts





















0 .1 2  m g /L
b





















0 .3 9  m g /L
c





















3 .1  m g /L
d





















5  m g /L
e





















1 0  m g /L
f





















1 5  m g /L
g





















2 0  m g /L
h





















2 5  m g /L
i





















1 0 0  m g /L
j





















1 5 7  m g /L
k
 
Figure 4.1: Percentage of cells with intracellular uptake, non-viable cells (intact, PI+), 
fragmented cells (i.e. cells loss) after 600 pulses of exposure to laser fluence ranging 
from 19 – 88 mJ/cm2 with CB nanoparticle concentrations ranging from a) 0.05 mg/L, 
b) 0.12 mg/L, c) 0.39 mg/L, d) 3.1 mg/L, e) 5 mg/L, f) 10 mg/L, g) 15 mg/L, h) 20 mg/L, 
i) 25 mg/L, j) 100 mg/L, and k) 157 mg/L. Total bioeffects (--) are also shown.  Data 
show average ± SD (n=3).  
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4.3.2 Effect of laser fluence 
 Laser energy was also used to increase the total energy input to the system. As such, 
we took all the data from Figure 4.1 and separated bioeffects based on laser fluence 
(Figure 4.2). At the lowest laser fluence, 19 mJ/cm2, little bioeffects – uptake, non-viable 
cells, and fragmentation – were observed for all CB concentrations evaluated (Figure 
4.2a). Bioeffects steadily increased with laser fluence, where at 25 mJ/cm2, little bioeffects 
were observed for dilute CB concentrations (i.e. < 1 mg/L), but significant uptake was seen 
at concentrations above that threshold (Figure 4.2b). Like the 19 mJ/cm2 data, minimal 
viability loss and fragmentation was observed for all concentrations at 25 mJ/cm2. At an 
intermediate laser fluence of 44 mJ/cm2, significant bioeffects were observed for CB 
concentrations > 1 mg/L, as uptake increased and plateaued with increasing CB 
concentration (Figure 4.2c). Total bioeffects saturated at higher laser fluence (i.e. 63 – 88 
mJ/cm2) for all CB concentrations tested (Figure 4.2d-f).  
We also estimated the effective CB-CB spacing and number of CB nanoparticles 
per cell. At the lowest laser fluence (i.e. 19 mJ/cm2), higher CB per cell values (i.e. > 1 
E+4) did not increase bioeffects greatly compared to lower CB per cell values. At 44 
mJ/cm2, we saw that bioeffects saturated at CB per cell values ≥ 1.7 E+3 and when the CB-
CB spacing was shorter than the radius of cell (10 µm). At even higher laser fluence (i.e. 
63 – 88 mJ/cm2), total bioeffects saturated at CB per cell values ≥ 5.5 E+3, suggesting that 
increasing the number of particles near the cell has a limiting effect. 
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Figure 4.2 Percentage of cells with intracellular uptake, non-viable cells (intact, PI+), 
fragmented cells (i.e. cells loss) after 600 pulses of exposure to laser fluence ranging 
from a) 19 mJ/cm2 b) 25 mJ/cm2, c) 44 mJ/cm2, d) 63 mJ/cm2, e) 75 mJ/cm2 and f) 88 
mJ/cm2 with CB nanoparticle concentrations ranging from 0.05 – 157 mg/L shown on 
the lower x axis. The first upper x axis shows the corresponding CB-CB spacing (i.e., 
from the center of each CB nanoparticle to its neighboring CB nanoparticle, assuming 
a cubic lattice) and the second upper x-axis shows the corresponding number of CB 
nanoparticles per cell. Total bioeffects (--) are also shown. Data show average ± SD 
(n=3). 
4.3.2.1 Bioeffect zones due to CB nanoparticle concentration and laser fluence 
 From Figure 4.1 and Figure 4.2, we noticed distinct regions or zones of bioeffects 
dependent on CB nanoparticle concentration and laser fluence. These thresholds were 
divided into different zones dependent on laser fluence with increasing CB concentration 
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(Figure 4.3) and dependent on CB concentration with increasing laser fluence (Figure 
4.4). In evaluating cells with intracellular uptake, three distinct zones emerged. The first 
zone for samples exposed to 19 and 25 mJ/cm2, with a few exceptions at high CB 
concentrations (i.e. ≥ 100 mg/L), exhibited low uptake with a few exceptions at CB 
concentrations > 100 mg/L (Figure 4.3ai). The next zone showed uptake plateaued at 44 
mJ/cm2, uptake increased and plateaued with increasing CB concentration (Figure 4.3aii) 
and finally in the last zone, uptake peaked and then decreased at higher fluence (i.e. 63 – 
88 mJ/cm2), uptake peaked and then decreased with increasing CB concentration (Figure 
4.3aiii). Viability loss (i.e. non-viable cells) was also divided into three zones of behavior. 
At low laser fluence (19 – 25 mJ/cm2), the viability loss was minimal (Figure 4.3bi). In 
the second zone, viability loss plateaued at 44 mJ/cm2 (Figure 4.3bii) and peaked, then 
decreased in the third zone at high laser fluence (i.e. 63 – 88 mJ/cm2) (Figure 4.3biii). 
Fragmentation occurred into two distinct zones (Figure 4.3ci-cii). The first zone, from 19 
– 44 mJ/cm2 (Figure 4.3ci), showed no fragmentation, in contrast to the second zone at 
higher laser fluence (i.e. 63 – 88 mJ/cm2), where significant fragmentation occurred 
(Figure 4.3cii).  
 Like the laser fluence zones, there were transition zones of bioeffects dependent on 
CB concentration with increasing laser fluence (Figure 4.4). Uptake behavior was divided 
into three zones, as well, with the first zone of low CB concentrations (i.e. 0.05 – 0.39 
mg/L) showing minimal uptake (Figure 4.4ai). In the second zone, uptake increased and 
plateaued with higher concentrations (i.e. 3.1 – 20 mg/L) (Figure 4.4aii), and at even 
higher concentrations (i.e. 25 – 157 mg/L), uptake peaked and then decreased in the third 
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zone (Figure 4.4aiii). Viability loss (Figure 4.4b) and fragmentation (Figure 4.4c) were 
also divided into two and three zones, respectively.  
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Figure 4.3: Bioeffects and thresholds as a result of varying CB nanoparticle 
concentration and increasing laser fluence. Percentage of cells with thresholds of 
intracellular uptake (ai – aiii) in which (ai) in Zone I little to no uptake occurs with 
increasing laser fluence. (aii) In Zone II, uptake plateaus and in (aiii) Zone III, uptake 
drops. Percentage of cells with thresholds of non-viable cells (bi-biii) in which (bi) in 
Zone I little to no cells exhibit non-viable cells. (bii) In Zone II, percentage of non-
viable cells plateaus with increasing laser fluence and (biii) Zone III, non-viable cells 
peak and then decrease with increasing laser fluence. Percentage of cells with 
thresholds of fragmentation (ci-cii). (ci) In Zone I little to no fragmentation occurs 
with increasing laser fluence. (cii) At higher CB concentration, fragmentation 
increases with increasing laser fluence. Data show average ± SD (n=3).  
 59 




































0 .0 5  m g /L
0 .1 2  m g /L
0 .3 9  m g /L
a i




































3 .1  m g /L
5  m g /L
1 0  m g /L
1 5  m g /L
2 0  m g /L
a ii




































1 5 7  m g /L
2 5  m g /L
1 0 0  m g /L
a iii

























0 .0 5  m g /L
0 .1 2  m g /L
0 .3 9  m g /L
3 .1  m g /L
5  m g /L
b i

























1 0  m g /L
1 5  m g /L
2 0  m g /L
2 5  m g /L
b ii

























1 0 0  m g /L
1 5 7  m g /L
b iii


























0 .0 5  m g /L
0 .1 2  m g /L
3 .1  m g /L
5  m g /L
1 0  m g /L
1 5  m g /L
2 0  m g /L
2 5  m g /L
0 .3 9  m g /L
c i


























1 0 0  m g /L
1 5 7  m g /L
c ii
 
Figure 4.4: Bioeffects and thresholds as a result of varying laser fluence and 
increasing CB concentration. Percentage of cells with thresholds of intracellular 
uptake (ai – aiii) in which (ai) in Zone I (19-25 mJ/cm2) little to no uptake occurs with 
increasing CB concentration. (aii) In Zone II, uptake plateaus (44 mJ/cm2) and in 
(aiii) Zone III, uptake drops (63-88mJ/cm2). Percentage of cells with thresholds of 
non-viable cells (bi-biii) in which (bi) in Zone I (19-25 mJ/cm2) little to no cells exhibit 
non-viable cells. (bii) In Zone II (44 mJcm2), percentage of non-viable cells plateaus 
with increasing laser fluence and (biii) Zone III (63-88 mJ/cm2), non-viable cells peak 
and then decrease with increasing CB concentration. Percentage of cells with 
thresholds of fragmentation (ci-cii). (ci) In Zone I (19-44 mJ/cm2) little to no 
fragmentation occurs with increasing CB concentration. (cii) At high laser fluence 
(63-88mJ/cm2), fragmentation increases with increasing CB concentration. Data show 
average ± SD (n=3).   
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4.3.3 Bioeffect zones depend on laser input energy and vaporization sites surrounding 
the cell 
 Overall, we posit that the bioeffect transition zone trends in Figure 4.3 and Figure 
4.4 highlight the importance of input energy and vaporization sites surrounding the cell, 
and more broadly the short-range interactions which drive TNET.  
 Our analysis reveal that laser fluence and CB concentration correlate strongly with 
bioeffects. In terms of laser fluence, we saw that low laser fluence (i.e. 19 – 25 mJ/cm2) 
resulted in minimal bioeffects for most CB concentrations (Figure 4.3ai, bi, ci), whereas 
bioeffects increased linearly with higher fluence (i.e. ≥ 44 mJ/cm2) (Figure 4.3biii). This 
suggests that total input energy, by way of laser fluence correlates with bioeffects.  
 Similarly, we saw that CB concentration correlated with bioeffects. Our previous 
estimations indicated that upon laser exposure, the CB nanoparticles heat up to hundreds 
of degrees Celsius and results in vaporization (Appendix B). Thus, we can think of 
nanoparticles as nucleation sites for vaporization. At lower nanoparticle concentrations, 
even when we increased fluence (Figure 4.4ai-ci), there were not enough 
nanoparticles/bubbles present to induce strong cellular bioeffects. At higher 
concentrations, more nanoparticles can absorb more laser energy, leading to the formation 
of more bubbles surrounding a cell. Therefore, a major conclusion from this set of studies 
is that energy input via CB nanoparticle concentration and more broadly the number of 
bubbles, is also a guiding parameter in determining the magnitude of bioeffects.  
4.3.4 Total energy input per cell 
4.3.4.1 CB nanoparticle concentration & Laser fluence 
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CB nanoparticles strongly absorb in the NIR [106], [107]. Calculations reveal that the 
percent absorbed at any given laser fluence is strongly dependent on the number of 
nanoparticles (i.e. the concentration). Based on Mie scattering theory used in our previous 
analysis [23], we can predict the total energy absorbed per pulse (Qin) by any concentration 
of CB nanoparticles and then estimate the total energy input per cell (Appendix B). The 
transition zones shown in Figure 4.3 and Figure 4.4 can be explained by the differences 
in energy input per cell (Figure 4.5).  
 The lack of bioeffects when the CB nanoparticle concentration is low (i.e. < 1 
mg/L) at laser fluence ≥ 44 mJ/cm2, is due to the relatively lower amount of energy input 
at those concentrations (Figure 4.5a). That is when little energy is absorbed, little energy 
is transduced to surrounding cells, resulting in little to no bioeffects. For comparison, even 
at the highest laser fluence used in this study, 88 mJ/cm2, the Qin for a nanoparticle 
concentration of 0.39 mg/L (2.7 x 10-1 mJ/pulse) is still only ~25% of the energy absorbed 
for a nanoparticle concentration of 3.1 mg/L at 44 mJ/cm2, where 1.09 mJ/pulse of energy 
is absorbed (Appendix B). Once sufficient laser energy is absorbed at or above the laser 
fluence threshold (i.e. 44 mJ/cm2) by higher nanoparticle concentrations (i.e. between 1 
and 100 mg/L), significant uptake, increase in viability loss and no fragmentation occurred 
(Figure 4.5a-c).  
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Figure 4.5: Total energy input per cell (mJ/cell) for a) cells with uptake, b) non-viable 
cells, and c) fragmented cells dependent on laser fluence and CB nanoparticle 
concentration data from Figure 4.3 & Figure 4.4. 
 The importance of energy input per cell is especially highlighted at high CB 
concentrations. High CB concentrations exhibited higher energy absorption, but only 
showed significant bioeffects at high laser fluence (i.e. 63 – 88 mJ/cm2) (Figure 4.5b-c). 
That is, the number of particles (concentration) in conjunction with the amount of energy 
they absorb (laser fluence dependent), are critical to the overall energy input per cell. 
Moreover, it is interesting to note that at higher nanoparticle concentrations (i.e. ≥ 25 
mg/L), the total energy absorbed dwarfs the energy absorption of lower concentrations for 
the same laser fluence. For example, at 44 mJ/cm2, the total energy absorbed for 157 mg/L 
is 55 mJ/shot, meaning there is a ~4900% increase in energy absorbed, compared to 1.1 
mJ/pulse for 3.1 mg/L. In the same way, when the CB nanoparticle concentration is lower, 
fragmentation does not occur, even at very high laser fluence (i.e., 63 – 88 mJ/cm2). Again, 
this can be attributed to the relatively low magnitude of total energy input per cell at those 
given concentrations (i.e. < 1 mg/L) (Figure 4.5c). 
4.3.4.2 Laser pulses & Cell concentration 
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 We also explored two other experimental parameters which affect cellular 
bioeffects – laser pulses and cell concentration. When these parameters were normalized 
for total energy input per cell, it also showed a strong correlation with energy and 
bioeffects. First, as the number of laser pulses increases, the total energy input per cell 
increases – however, the magnitude of bioeffects was strongly related to the CB 
nanoparticle concentration and the laser fluence (Figure 4.5). As such, we tested higher 
CB concentrations (i.e. 25 & 157 mg/L). We saw that as the number of pulses increased, 
bioeffects became stronger (Figure 4.6a). The apparent shielding effect of bubbles at high 
CB nanoparticle concentration supports the idea of direct cell-bubble interaction that can 
occur over a distance (and can be blocked by the presence of other bubbles in between). 
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Figure 4.6: a) Cells exposed to 1 – 1800 laser pulses at 88 mJ/cm2 with ai) 25 mg/L 
and aii) 157 mg/L CB particle concentration. Data shows percentage of cells with 
intracellular uptake, non-viable cells, fragmented cells and total bioeffects. b) Total 
energy input per cell (mJ/cell) for bi) cells with uptake, bii) non-viable cells, and bii) 
fragmented cells dependent on laser pulses and CB concentration. Single shot mode 
was used for pulses ≤ 50, exposed manually at 1 shot every 5 secs. Pulses ≥ 150 were 
exposed at a frequency of 10 shots/sec. Data show average ± SD (n = 3). 
 Cell concentration was varied to better understand these direct interactions. We saw 
total energy input per cell decreased linearly with increasing cell concentration, because 
the total input energy was divided among more cells (Figure 4.7b). For example, at 25 
mg/L, there was a decrease in bioeffects above 106 cells/mL (Figure 4.7a(iii)). Based on 
the cell-cell spacing at this point, there seems to be a protective effect of higher cell 
concentrations, decreasing overall effects of TNET. Since cellular bioeffects became 
weaker with increasing cell concentration (i.e. closer cell-cell spacing) (Figure 4.7b), this 
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once again suggests that there are direct interactions between cells and neighboring 
bubbles, as opposed to a change in the overall environment around the cells (e.g. elevating 
pressure), which would not be significantly affected by cell concentration. 





















0 .3 9  m g /L
i
U p ta k e
N o n -v ia b le
F ra g m e n te d
T o ta l b io e f fe c ts
1 2 91 0 38 14 8







































3 .1  m g /L
ii
1 2 91 0 38 14 8







































2 5  m g /L
iii
1 2 91 0 38 14 8





















































[C B ]  f r o m  F ig  5
2 5  m g /L
3 .1  m g /L
0 .3 9  m g /L






















































Figure 4.7: a) Percentage of cells with intracellular uptake, non-viable cells, and 
fragmented cells exposed with ai) 0.39 mg/L CB, aii) 3.1 mg/L CB and aiii) 25 mg/L 
CB. Cell concentration was varied from 0.1, 0.5, 1.0, 2.0 and 10 x 106 cells per mL 
(lower x-axis) and the corresponding cell-cell spacing (i.e., from the center of each cell 
to its neighboring cells, assuming a cubic lattice) is shown on the upper x-axis and the 
corresponding number of CB nanoparticles per cell is shown in the second upper x-
axis. Data also shows total bioeffects. Samples were exposed for 600 pulses at 88 
mJ/cm2. Data show average ± SD (n=3). b) Total energy input per cell (mJ/cell) for 
bi) cells with uptake, bii) non-viable cells, and biii) fragmented cells dependent on cell 
concentration and CB nanoparticle concentration.  
4.3.5 Dampening short-range interactions with medium viscosity 
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 Previous studies indicated that CMC aqueous solutions retain nearly similar 
thermal properties (e.g. heat capacity, thermal conductivity) as pure water [108]. Thus, to 
dampen local fluid mechanics energy transfer from irradiated CB nanoparticles while 
maintaining similar thermal properties, we increased the viscosity of the suspension 
medium (i.e. serum-free RPMI) nearly 13-fold compared with 2% CMC (Methods). 
Samples were exposed with 3.1 mg/L CB because this nanoparticle concentration had 
previously shown efficacious delivery (Figure 4.1). With a more viscous medium, 
intracellular delivery of calcein to the cells was significantly reduced (Figure 4.8a). Due 
to a higher viscosity, some cells were lost in sample transfer during experiments (data not 
shown). That withstanding, viability loss was similar for 0% CMC and 2% CMC samples 
at both 44 and 88 mJ/cm2 (Figure 4.8b).  
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Figure 4.8: a) Cells with uptake and b) non-viable cells in suspension with 0% and 
2% CMC (w/v) + RPMI, exposed to 44 mJ/cm2 and 88 mJ/cm2 for 600 pulses minute 
with 3.1 mg/L CB concentration. Asterisk (*) indicate data is statistically different 
from other condition (ANOVA, **p < 0.01, ****p<0.0001). Data show average ± SD 
(n=3). 
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 Other work using microbubbles for sonoluminescence applications have shown that 
increasing the viscosity of the liquid drastically reduces the bubble’s ability to expand 
[109]. It is possible that the timescale of the bubble growth rate was decreased significantly 
enough to suppress bioeffects. Since the growth rate of the bubble should be reduced in a 
more viscous medium, the resulting vapor bubble velocity and acceleration may have 
resulted in less short-range energy transfer in the form of local fluid displacement and/or 
near-field pressure release.  
 In addition, being that the thermal properties of the medium were relatively 
unaltered with the addition of CMC, these results have some implications for TNET 
mechanistically. The results seem to point to a fluid mechanical method rather than a 
thermal mechanism which leads to poration of the membrane and subsequent molecular 
delivery. Had a thermal mechanism been dominant in TNET, we would have expected to 
see little to no significant change in bioeffects upon the addition of CMC, however we saw 
that bioeffects were significantly dampened. This dampening again supports a possible 
hindrance of fluid mechanical energy transfer from bubble to cell upon laser irradiation of 
the carbon nanoparticles.  
4.3.6 Implications of these various parameters 
 This study examined the effect of four experimental parameters – laser fluence, 
number of laser pulses, CB nanoparticle concentration, and cell concentration – on cellular 
bioeffects, including intracellular uptake of molecules, loss of cell viability (in intact cells) 
and cell fragmentation. 
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 For increasing laser fluence, number of pulses and CB nanoparticle concentration, 
and for decreasing cell concentration, cellular bioeffects became increasingly stronger. At 
the weakest exposure conditions, no significant effects on cells were seen. As exposure 
conditions became stronger, (i) significant intracellular uptake was seen and increased, (ii) 
then loss of cell viability began to occur and increased, while intracellular uptake 
correspondingly decreased and (iii) finally at the strongest exposure conditions, cell 
fragmentation was observed and increased, while intracellular uptake and loss of cell 
viability decreased (Figure 4.3 & Figure 4.4). 
 The effects of these four parameters could be accounted for by correlation with a 
single parameter: total energy input per cell (Figure 4.5, Figure 4.6b, Figure 4.7b). These 
parameters increased linearly with laser fluence and number of laser pulses, as well as with 
CB nanoparticle concentration, because more nanoparticles were able to absorb more laser 
light. It decreased linearly with cell concentration because the energy needed to be divided 
up among more cells. While all the data fell onto a single curve when plotting each of the 
bioeffects versus total energy input per cell (Figure 4.5), the data at the highest CB 
nanoparticle concentrations ( ≥100 mg/L) were shifted to higher energy to achieve the same 
bioeffects. We believe this is due to bubbles created around CB nanoparticles shielding 
[23] the interactions between neighboring cells and more-distant bubbles. 
 Overall, these data, in context with the broader literature, suggest that each laser 
pulse administers a certain amount of energy into each nanoparticle. Each nanoparticle 
transduces that energy into thermal, fluid mechanical and acoustic energy emissions that 
are transmitted to neighboring cells. The cumulative energy transmitted to cells determines 
the cellular bioeffects, and it does not matter what combination of laser fluence, number of 
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laser pulses, CB nanoparticle concentration or cell concentration values together determine 
that cumulative energy transmitted to each cell. 
 Understanding bioeffect transition zones in addition to the magnitudes of total 
energy input per cell is imperative for future TNET applications. Future studies to detail 
the type of energy transduction associated with short-range interactions, i.e. mechanical 
and/or thermal stresses, is warranted and moreover, understanding the magnitude of the 
energy transduced will be instructive to further developing TNET into a promising 
intracellular drug delivery platform. 
4.4 Conclusion 
In this study, we investigated four parameters – CB nanoparticle concentration, 
laser fluence, laser pulses, and cell concentration – which influence short-range cell–CB 
nanoparticle interaction and resulting bioeffects. The results from this work provide an 
important theoretical framework to understand short-range cell–CB nanoparticle 
interactions in TNET. Our results revealed total energy input per cell correlates strongly 
with cellular bioeffects. These results provide a deeper fundamental biophysical 
understanding for TNET.   
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CHAPTER 5. EFFECTS OF NANOSECOND-PULSED LASER 
IRRADIATION OF CARBON NANOTUBES ON 
INTRACELLULAR UPTAKE AND CELL VIABILITY, AND 
THEIR RELATIONSHIP TO PHOTOACOUSTIC PRESSURE 
5.1 Introduction 
Previously, we investigated the long-range acoustics associated with a pressure 
field produced by laser-irradiated CB nanoparticles and its role in intracellular delivery 
[23]. We found that the laser-irradiated CB nanoparticles were heated to more than 1000 
K and generated vapor bubbles that rapidly expand and release acoustic waves [23]. Two 
length scales of cell-bubble interaction were hypothesized: 1) long-range, indirect, 
cumulative acoustic emissions from bubbles or 2) short-range, local cell-bubble 
interaction. Several calculations and experiments suggested that a cell only experiences 
pressure from the nearest CB particles due to a shielding effect from a cumulative field of 
carbon nanoparticles [23]. We further posited that observed bioeffects were due to possible 
fluid mechanical and/or thermal mechanisms, in which liquid momentum or direct heat 
transfer from the hot vapor bubble to the cell (i.e. short-range effects). This suggested that 
spatially cumulative acoustic interactions (i.e. long-range effects) were not the dominant 
mechanism of TNET’s effects on cells. 
While previous studies have characterized the photoacoustic properties of CB 
nanoparticles [15], [23], [69], [71], [110]–[112] and we have used CB nanoparticles 
extensively in our intracellular delivery work [13], [14], [23], [72], [73], use of carbon in 
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different forms, e.g., carbon nanotubes (CNT), has not been studied before in the context 
of intracellular delivery by TNET. Therefore, in this study we compared the cellular 
bioeffects, as well as the photoacoustic output, from CB nanoparticles, multi-walled CNTs 
(MWCNT) and single-walled CNTs (SWCNT). We hypothesized that TNET would occur 
differently in these three types of carbon nanoparticles and thereby have different effects 
on intracellular delivery and cell viability. We further hypothesized that the photoacoustic 
output from these three types of nanoparticles would be different, and assessed whether the 
diverse bioeffects from the different types of nanoparticles could be explained on the basis 
of photoacoustic pressure (i.e., whether bioeffects would correlate with photoacoustic 
pressure for all three types of nanoparticles.  
5.2 Methods 
5.2.1 Nanoparticle preparation 
Three carbon nanoparticle materials were utilized in this study—CB, SWCNT, and 
MWCNT. CB nanoparticles were obtained from Cabot Corporation (Boston, MA) and 
prepared as previously described [14] with a stock concentration of 0.40 g/L. Per the 
manufacturer, the individual CB nanoparticles were 25 nm in diameter, but aggregated to 
form clusters of 200 nm diameter. We performed dynamic light scattering (DLS) 
measurements (ZetaSizerNano, Malvern Instruments, Lavern, Worcestershire, UK), which 
indicated that the CB nanoparticles (i.e., clusters) had a diameter of 200 ± 6 nm (n=10), 
which is similar to previous studies [13], [14].  
SWCNT and MWCNT suspensions (Nanostructured & Amorphous Materials, 
Houston, TX) were diluted to stock concentrations of 1.056 g/L and 0.304 g/L, 
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respectively. Per the manufacturer, the individual SWCNT were 5-30 µm in length and 1-
2 nm in diameter, whereas the individual MWCNT were 10-30 µm in length and 20-30 nm 
in diameter. DLS studies showed that SWCNT and MWCNT bundled into aggregates with 
diameters of 395 ± 20 nm (n=10) and 252 ± 23 nm (n=10), respectively. Although DLS is 
more accurate for spherical particles, previous studies have reported that CNT tend to curl-
up and agglomerate [113], and aggregate size has been measured using DLS [113]–[115].  
5.2.2 Laser system 
Acoustic measurements and in vitro exposures were conducted with a Nd:YAG 
solid-state laser (Continuum Powerlite II Plus, San Jose, CA), which was used to apply 5-
9 ns duration pulses of 1064 nm wavelength, at a frequency of 10 Hz (i.e., 10 pulses per 
second). Laser pulse energy was varied by changing the laser amplifier voltage settings.  
 For in vitro delivery experiments, the laser beam, with an initial diameter of 12 mm, 
was passed through an 8 mm aperture to obtain a more uniform laser energy profile. A 
diverging lens was positioned after the 8 mm aperture to illuminate the exposure area (4 
cm2) of the cuvette used to hold cells and nanoparticles in suspension. For photoacoustic 
measurements, the 12 mm laser beam was passed through a 2 mm aperture to minimize the 
spot size. 
5.2.3 Acoustic measurements 
Acoustic measurements of the three nanoparticle systems (i.e. CB, MWCNT, 
SWNCT) were conducted as described in previous work [23]. In brief, nanoparticle 
suspensions were pumped at a flow rate of 85 mL/h (New Era Pump Systems, Farmingdale, 
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NY) as a stable vertical stream from a ‘supply’ needle into a glass-walled tank filled with 
degassed water at 22 ± 2 ºC. As the laser system irradiated a small section of the stream, a 
needle hydrophone (HNC-0200, ONDA, Sunnyvale, CA) received the photoacoustic 
signal. Before and after laser exposures, a focused ultrasound transducer (Panametrics 
V310-SU, Olympus) connected to a pulse receiver (Panametrics 5072PR, Olympus) was 
used to estimate the position of the hydrophone tip relative to the nanoparticle stream from 
the cross-correlation of scattered signals from the needle tip and hydrophone tip. 
Nanoparticle accumulation in the water tank was mitigated by operation of a collection 
system (needle, tubing and syringe pump) positioned approximately 3 cm beneath the 
supply needle. Data were collected with a 100 MHz digitizer (CS320A, Cleverscope, 
Auckland, New Zealand). Acoustic pressures were determined using a complex-valued 
calibration of the needle hydrophone [23]. 
5.2.4 Cell culture & in vitro experiments 
 Human prostate cancer cells (DU145, American Type Culture Collection, 
Manassas, VA) were cultured as monolayers in a humidified atmosphere of 95% air and 
5% CO2 at 37°C in RPMI-1640 medium (Cellgro, Herndon, VA) supplemented with 100 
g/mL penicillin-streptomycin (Cellgro) and 10% (v/v) heat-inactivated fetal bovine serum 
(FBS) (Corning, Palo Alto, CA). Cells were harvested at 80-90% confluence for 
experiments by trypsin/EDTA (Cellgro) digestion, washed with serum and then re-
suspended in RPMI at a cell concentration of 106 cells/mL. DU145 cells were used as the 
model cell line for these experiments because they have been widely used and characterized 
in previous drug delivery studies [13], [14], [20].  
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 Harvested cells were transported in 1.5 mL microcentrifuge tubes and stored on ice 
until exposure. Optically clear glass cuvettes (Starna Cells, Atascadero, CA) contained 520 
μL of cells; CB, SWCNT, or MWCNT added at a final concentration of 25 mg/L, 70 mg/L, 
20.1 mg/L respectively; and high-purity calcein (Molecular Probes, Eugene, OR) added as 
an uptake marker at a final concentration of 10 μM. The CB, SWCNT, and MWCNT 
concentrations were selected as ones that exhibited the same light transmittance under our 
laser exposure conditions, as determined by spectrophotometry.  
 Following exposure, the contents of the cuvette were transferred back into the 
microcentrifuge tubes with a transfer pipette and stored on ice to reduce uptake due to 
endocytosis. To label non-viable cells >30 min post-irradiation, propidium iodide (PI, 
Invitrogen, Grand Island, NY) was added at a concentration of 13.5 μM and cells were 
incubated for 10 min. Samples were then washed at least three times with phosphate buffer 
saline (PBS) to remove extracellular fluorescence from the solution. 
5.2.5 Data collection and processing 
5.2.5.1 In vitro exposure experiments 
A flow cytometer (BD Accuri, BD Biosciences, San Jose, CA) quantified bioeffects 
in terms of live cells with intracellular uptake (i.e. intact cells with green fluorescence of 
calcein loading and without red fluorescence of propidium iodide (PI) staining) and non-
viable cells (i.e. intact cells with PI staining). Calcein fluorescence was measured with a 
530/28 nm bandpass filter and PI was measured with a 670 nm longpass filter. Samples 
were run at a constant flow rate of 35 μL/min for 1 min.  
 75 
A negative, ‘sham’ control containing cells in RPMI that were not exposed to laser 
was used to construct a cell population gate in the forward-scattered and side-scattered 
analysis. Cells within this gate were considered to be intact cells. To account for possible 
cell loss due to fragmentation, the number of live cells (i.e., PI-negative) for each exposed 
sample subtracted from the number of live cells for the sham was taken to be the number 
of fragmented cells, which appeared as a field of debris at low forward and side scatter 
[80].  
5.2.6 Statistical analysis 
5.2.6.1 In vitro exposures 
A minimum of three replicates was used for all conditions, which allowed for the 
calculation of means and standard deviations (which is how all data are presented). The 
null hypothesis was that the average fraction of cells with uptake or viability between a 
sham sample and an exposed sample were equal. The equality of means response between 
exposed samples and sham samples was tested with ANOVA (α = 0.05). The equality of 
mean response was tested with 1-way or 2-way ANOVA followed by post hoc Tukey’s 
pairwise comparison, depending on the number of data points, using GraphPad Prism 6 
(GraphPad Software, La Jolla, CA).  
5.3 Results  
5.3.1 Effect of CB on intracellular uptake, cell viability and cell fragmentation  
We determined the effect of CB, MWCNT and SWCNT on intracellular uptake, 
cell viability and cell fragmentation due to laser irradiation over a range of fluence values. 
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Laser irradiation with CB nanoparticles showed progressively stronger bioeffects with 
increasing laser fluence (Figure 5.1). Initially, intracellular uptake increased at a laser 
fluence ≥ 25 mJ/cm2, peaked at 44 mJ/cm2 with 45% of cells exhibiting uptake and then 
decreased at 44 – 100 mJ/cm2 (Figure 5.1a). When uptake decreased, loss of cell viability 
increased at 44 mJ/cm2, peaked at 63 mJ/cm2 and then decreased and plateaued at 75 – 100 
mJ/cm2 (Figure 5.1b). When cell viability loss decreased, cell fragmentation increased at 
75 – 100 mJ/cm2 (Figure 5.1c).  
Finally, when accounting for cells that exhibited any bioeffect (i.e., uptake, viability 
loss or fragmentation), there was a steady increase in bioeffects starting at 25 mJ/cm2 until 
it plateaued when ~100% of cells were affected at 63 – 100 mJ/cm2 (Figure 5.1d). These 
data suggest that increasing laser fluence in the presence of CB caused progressively 
stronger bioeffects, starting with intracellular uptake (i.e., reversible permeabilization), 





Figure 5.1: (left y-axis) Percentage of cells suspended with CB nanoparticles with a) 
intracellular uptake, b) non-viable cells (i.e. PI+), c) fragmented cells and d) total 
bioeffects (uptake, non-viable cells and fragmented) after 1 minute of pulsed exposure 
to laser fluence ranging from 19 - 100 mJ/cm2. Data show average ± SD (n=3). (right 
y-axis) Cumulative peak pressure output of CB nanoparticles after exposure to laser 
fluence ranging from 19 – 100 mJ/cm2. Data show average ± SD (n ≥ 100). 
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5.3.2 Effect of MWCNT on intracellular uptake, cell viability and cell fragmentation  
Laser irradiation in the presence of MWCNT showed behavior similar to CB, but 
with important differences. Initially, significant uptake was seen at 19 mJ/cm2, plateaued 
at 44 – 75 mJ/cm2 with up to ~50% of cells showing uptake, and then decreased at 88 – 
100 mJ/cm2 (Figure 5.2a). Compared to CB, uptake caused by laser irradiation with 
MWCNT was first observed at a lower fluence, was seen in a higher percentage of cells 
with uptake, and was maintained at high levels over a much broader range of fluence 
values. In contrast to CB, cells exposed with MWCNT never experienced significant loss 
of cell viability over the range of conditions studied (Figure 5.2b). Instead, cellular 
bioeffects transitioned directly from uptake to uptake and fragmentation at fluence ≥ 63 
mJ/cm2 (Figure 5.2c). Total bioeffects increased from 19 mJ/cm2 until it plateaued at 63 – 
100 mJ/cm2.  
These data show that the only condition where there was significant uptake and no 
significant cell viability loss or fragmentation due to exposure with CB was 25 mJ/cm2 at 
a level of 24% of cells with uptake. In contrast, exposure with MWCNT caused significant 
uptake without significant cell viability loss or fragmentation over the range 20 – 44 
mJ/cm2 at a peak level of 50% of cells with uptake. This indicates that use of MWCNT 
may be preferred over CB when the objective is maximizing intracellular uptake while 




Figure 5.2: (left y-axis) Percentage of cells suspended with MWCNT with a) 
intracellular uptake, b) non-viable cells (i.e. PI+), c) fragmented cells and d) total 
bioeffects (uptake, non-viable cells and fragmented) after 1 minute of pulsed exposure 
to laser fluence ranging from 19 - 100 mJ/cm2. Data show average ± SD (n=3). (right 
y-axis) Cumulative peak pressure output of MWCNT after exposure to laser fluence 
ranging from 35 – 100 mJ/cm2. Data show average ± SD (n ≥ 100). 
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5.3.3 Effect of SWCNT on intracellular uptake, cell viability and cell fragmentation  
Laser irradiation in the presence of SWCNT did not exhibit significant changes in 
uptake, viability loss or fragmentation over the range of laser fluences studied, 19 – 100 
mJ/cm2 (Figure 5.3). This behavior is dramatically different from what we saw using CB 
or MWCNT.  
We wanted to know if laser irradiation with SWCNTs would ever cause bioeffects, 
and therefore exposed cells to laser irradiation with SWCNT for up to 3 min (instead of the 
1 min exposures used previously) at 25 mJ/cm2. However, increasing the length of 
exposure did not significantly alter bioeffects (Figure 5.4a). Next, we increased the laser 
exposure to 5 min and increased laser fluence to 44 – 75 mJ/cm2. At these extreme 
conditions, there was still insignificant intracellular uptake (Figure 5.4b(i)) and little cell 
fragmentation (Figure 5.4b(iii)), but there was significant viability loss at 63 – 75 mJ/cm2 
(Figure 5.4b(ii)). This outcome may be due to thermal effects on cells caused by heat 
transfer from the SWCNT, which is similar to other studies showing that continuous NIR 




Figure 5.3: (left y-axis) Percentage of cells suspended with SWCNT with a) 
intracellular uptake, b) non-viable cells (i.e. PI+), c) fragmented cells and d) total 
bioeffects (uptake, non-viable cells and fragmented) after 1 minute of pulsed exposure 
to laser fluence ranging from 19 - 100 mJ/cm2. Data show average ± SD (n=3). (right 
y-axis) Cumulative peak pressure output of SWCNT after exposure to laser fluence 




Figure 5.4: Percentage of cells suspended with SWCNT after a) exposure to 25 
mJ/cm2 for 0.5 – 3 min that are ai) intracellular uptake, aii) non-viable c, aiii) 
fragmented cells and aiv) total bioeffects (uptake, non-viable and fragmented). 
Percentage of cells with SWCNT after b) exposure to higher laser fluence (i.e. (44-75 
mJ/cm2) for 5 min with bi) intracellular uptake, bii) non-viable cells, biii) fragmented 
cells and biv) total bioeffects (uptake, non-viable and fragmented). Data show average 
± SD (n=3). 
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5.3.4 Characterization of photoacoustic pressure emitted by laser-irradiated 
nanoparticles  
During TNET, a variety of energy transfers can occur, including momentum 
transfer due to the rapidly expanding bubbles formed around the nanoparticles and heat 
transfer from the hot nanoparticles and surrounding bubbles. We hypothesized that the 
varied effects of the three different types of carbon nanoparticles studied here might be 
explained by differences in photoacoustic pressure generated by the rapidly expanding 
bubbles.  
First, we characterized photoacoustic pressures generated by laser-irradiation of the 
nanoparticles (Figure 5.5). For all three types of nanoparticles, there was a primarily 
positive pressure pulse, consistent with the rapid expansion of bubbles due to heat transfer 
from the hot nanoparticles to the surrounding medium, followed by a slow cooling of the 
bubbles that did not generate a significant negative pressure. A mostly positive pressure 
pulse also means that stresses due to the acoustic radiation are largely compressive in the 
free field and that there were no significant pressure oscillations. The pressure rise time 
was on the order of 20-40 ns and the pulse duration was hundreds of nanoseconds, which 
is an order of magnitude longer that the laser pulses and is consistent with prior calculations 




Figure 5.5: Cumulative peak pressure was measured for water, CB, SWCNT, 
MWCNT irradiated by nanosecond pulses. Pressure waveforms of a) water, b) CB, c) 
MWCNT and d) SWCNT showing pressure (kPa) versus time (µs) after exposure to 
in-water laser fluence of 200 mJ/cm2. 
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In addition to these similarities, the absolute pressures are significantly different 
among the three different types of nanoparticles when exposed at the same laser conditions 
using nanoparticle concentrations that absorbed roughly the same amount of energy. For 
example, when exposed to an in-water laser fluence of 200 mJ/cm2, laser irradiation of CB 
generated a peak pressure of 292 ± 23 kPa (mean ± standard deviation) over the ensemble 
of pulses collected (Figure 5.5b). In contrast, the MWCNT generated a much lower 
pressure of 69 kPa ± 5 kPa (Figure 5.5c) and the SWCNT generated a much higher 
pressure of 549 ± 49 kPa (Figure 5.5d). Although SWCNT generated the highest 
photoacoustic pressure, it caused the weakest cellular bioeffects (Figure 5.3). While CB 
and MWCNT had significantly different pressures, they caused similar bioeffects over a 
range of conditions (Figure 5.1 and Figure 5.2). These findings suggest that there is a poor 
correlation between photoacoustic pressure and cellular bioeffects.  
5.3.5 Correlation between photoacoustic pressure and cellular bioeffects 
To better understand the relationship between pressure and cellular bioeffects, we 
examined the peak photoacoustic pressures associated with each of the cellular exposures 
to see if there might be a correlation. For CB, as pressure continuously increased with 
increasing laser fluence, uptake and viability loss each increased, peaked and declined 
(Figure 5.1a, b), cell fragmentation increased above a threshold fluence (Figure 5.1c) and 
total bioeffects increased and plateaued (Figure 5.1d). For MWCNT, pressure showed a 
similar relationship with uptake, fragmentation and total bioeffects (Figure 5.2a, c, d), but 
there was no change in nonviable cells while pressure steadily increased (Figure 5.2b). 
Finally, for SWCNT, as pressure increased, there were little or no bioeffects (Figure 5.3). 
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Review of the acoustic data showed a tendency for pressure pulse length to 
modestly increase at lower fluences, so that peak pressure may not always track energetic 
output. This effect was quantified using time-averaged acoustic potential energy density, 
which showed relatively minor differences in fluence trend from those obtained with peak 
pressure (Figure 5.6), suggesting that neither of the two cumulative acoustic quantities was 
universally correlated to bioeffects. Estimates of total acoustic energy emitted by the 
nanoparticle stream, paired with calculations of energy absorbed by the CB nanoparticles 
[23] indicated that the proportion of absorbed energy converted into acoustic energy is no 
more than 0.51% at the highest fluence evaluated (100 mJ/cm2). Since this fraction is so 
small, it is perhaps less surprising that the acoustic correlations to bioeffects are so weak. 
Acoustic monitoring as performed here may indicate vapor bubble formation, but may not 
have value as an indicator of photoporation-mediated drug delivery. 
 
Figure 5.6: (left y-axis) Acoustic potential energy density signal, (right y-axis) peak 
acoustic pressure signal, and pressure noise (bottom curve) as a function of in-water 
fluence for laser-irradiation of a) CB nanoparticle, b) MWCNT, and c) SWCNT. Data 
show mean and SD (n ≥ 100). Background noise was measured in the absence of laser 
irradiation. Time-averaged acoustic potential energy density was calculated as 𝑼 =
(𝟏 𝝉𝝆𝒄𝟐⁄ ) ∫ 𝒑(𝒕)𝟐𝒅𝒕
𝝉
𝟎
 where 𝒑(𝒕) is the acoustic pressure as a function of time, 𝝉 is the 
laser pulse repetition period, and 𝝆 and 𝒄 are the medium density and sound speed, 
respectively.   
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While there may be a correlation between photoacoustic pressure and bioeffects 
under some circumstances, it will be most informative to combine all the data to determine 
if there is a universal correlation of bioeffects with pressure, independent of type of 
nanoparticle, to serve as a unifying parameter more closely related to mechanism of action. 
We therefore plotted bioeffects (e.g., uptake) as a function of peak photoacoustic pressure 
generated by CB, MWCNT, and SWCNT (Figure 5.7a). This analysis showed that peak 
pressure does not serve as a unifying parameter (i.e., the data do not all fall on a common 
curve on any of the graphs) and therefore does not explain the disparate bioeffects caused 
by different types of nanoparticles. While the bioeffects of CB and MWCNT often show 
similar functionality, there is an abscissa shift such that bioeffects caused by MWCNT 
occur at lower pressures than when they are caused by CB.  
We also plotted bioeffects caused by CB, MWCNT and SWCNT as a function of 
laser fluence, which can be thought of as a measure of total energy input into the system 
(Figure 5.7b). While the data again do not all fall onto common curves, the correlations 
were much better compared to peak photoacoustic pressure (Figure 5.7b). Although 
SWCNT had little effect on cells and MWCNTs did not generate nonviable cells, the CB 
and MWCNT data follow each other reasonably well, suggesting that the total energy input 
is a better correlation – and perhaps a better mechanistic indicator – for bioeffects caused 




Figure 5.7: Percentage of i) cells with intracellular uptake, ii) non-viable cells (PI+), 
iii) fragmented cells, and iv) total bioeffects after exposure with CB, MWCNT, and 
SWCNT with a) increasing peak pressure and b) increasing laser fluence. Expected 
pressures for those not physically measured were interpolated from measured 
pressure to plot bioeffects over same range of laser fluence as in vitro experiments. 
5.4 Discussion  
The purpose of this study was to investigate the effect of different carbon 
nanoparticles – CB, MWCNT, SWCNT – in terms of their TNET-associated bioeffects, as 
well as their photoacoustic output. We found that each type of nanoparticle had different 
bioeffect “profiles” and had different photoacoustic emission intensities.  
Laser-irradiated CB affected cells in ways that led to reversible permeabilization 
(i.e. viable cells with intracellular uptake) without significant viability loss at mild 
conditions (e.g., low laser fluence) (Figure 5.1a); a combination of reversible 
permeabilization and irreversible permeabilization (i.e., nonviable, intact cells) at moderate 
conditions (Figure 5.1a-b); and cell fragmentation at the strongest conditions (Figure 
5.1c). Laser-irradiated MWCNT, on the other hand, affected cells in ways that only led to 
 89 
reversible permeabilization at mild or moderate conditions (Figure 5.2b) and at strong 
conditions there was also fragmentation (Figure 5.2c). Interestingly, SWCNT did not 
cause reversible permeabilization (Figure 5.3b), but at very strong conditions (i.e. high 
laser fluence and longer exposures) caused irreversible permeabilization (Figure 5.3c). 
Since MWCNT showed the broadest range of laser fluence values leading to reversible 
permeabilization without viability loss, they may be an attractive nanoparticle system for 
TNET-mediated intracellular drug delivery applications. CNTs have been previously used 
for other drug delivery applications [119], [120] and have been shown to be nontoxic upon 
surface functionalization [121], [122] in some in vivo scenarios [123]–[125]. 
The three types of nanoparticles released mechanical energy in the form of 
photoacoustic waves. The experimental data showed that all nanoparticles generated 
increasing photoacoustic pressure with increasing laser fluence, but the absolute peak 
pressure intensity varied with the type of nanoparticle. Cumulative peak photoacoustic 
pressure was highest for SWCNT, followed by CB, and then MWCNT (Figure 5.5). This 
trend does not mirror that of bioeffects, where SWCNT caused almost no bioeffects, but 
had the highest peak pressure (Figure 5.3). Moreover, the pressure waveform (i.e., rise-
time, pulse duration) was similar for each type of nanoparticle (Figure 5.5), which also 
does not correlate with bioeffects, which varied with type of nanoparticle. Because the 
different types of nanoparticle had different geometries and aggregate sizes, the radial 
velocity and acceleration profiles of the bubbles they generated could be different, but 
analysis of these effects is beyond the scope of this study. Also, the concentration of each 
type of nanoparticle was different (i.e. to provide similar laser energy absorption), which 
means that the energy absorbed on a per-nanoparticle basis was different for each type of 
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nanoparticle; this may also play a role in explaining the effect of nanoparticle type on 
bioeffects.  Altogether, the lack of correlation between features of the pressure output and 
cellular bioeffects caused by different types of nanoparticles suggests that the 
photoacoustic pressure may not play a direct mechanistic role in the observed bioeffects. 
Photoporation-mediated bioeffects are caused by the conversion of laser light 
energy into other forms of energy by carbon nanoparticles that act as the energy 
transducers. One form of energy emitted by the nanoparticles is in the form of an acoustic 
wave created by a rapidly expanding gas bubble. Our data suggest that this form of energy 
is not mechanistically responsible for the observed bioeffects. The bubble growth also 
pushes fluid that can impact cells, imparting compressive and/or shear forces to the cell 
membrane that could cause bioeffects. The nanoparticles and bubbles are also very hot 
(e.g., >> 100°C), so there can be heat transfer to cells that could lead to bioeffects [23]. 
Our previous work suggested that bioeffects from photoporation were not due to 
long-range acoustic effects, but were dominated by short-range effects [23]. Data from the 
present study also suggested that long-range cumulative acoustic pressure was not likely 
the dominant mechanism in TNET given the lack of correlation between bioeffects and 
photoacoustic pressure from the different types of nanoparticles, However, given the 
complex pressure behavior close to the pressure source [126], the pressure within a length 
scale on the order of the largest nanoparticle/bubble dimensions (i.e. 1 – 10 µm for the 
conditions tested here) may be mechanistically important and provide additional insight. 
For example, the near-field pressure and associated fluid motion from rod-like 
nanoparticles (e.g. CNTs) should be quite different from spherical nanoparticles (e.g. CB) 
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[127] and, in that way, explain the varied bioeffects seen for the different types of 
nanoparticles. 
 In contrast to cumulative photoacoustic pressure, total energy input to the 
nanoparticles correlated better with bioeffects (Figure 5.7b). This suggests that a different 
form of energy output from the nanoparticles that correlates with energy input is 
mechanistically responsible for TNET-mediated bioeffects. Future work should investigate 
these other forms of energy output, including short-range cell-nanoparticle interactions (i.e. 
1 - 10 µm) mediated by thermal, fluid mechanical and/or near-field pressure energy transfer 
from nanoparticles and their surrounding bubbles to nearby cells, either directly or via the 
surrounding medium to transiently porate cell membranes.  
5.5 Conclusion 
 In this study, we compared the cellular bioeffects of CB, MWCNT and SWCNT 
during nanosecond-pulsed NIR laser irradiation. Using DU145 prostate cancer cells as a 
model system, we found that each nanoparticle had a different bioeffect “profile” as laser 
fluence increased. CB showed a clear transition from cells with uptake of molecules (i.e., 
reversibly permeabilized cells) to non-viable cells (i.e., irreversibly permeabilized cells that 
remained intact) to fragmented cells (i.e., appearing as cellular debris) with increasing laser 
fluence. In contrast, cells exposed to laser-irradiated MWCNT exhibited uptake at higher 
levels over a broader range of laser fluence values compared to CB nanoparticles. 
Moreover, very few non-viable cells were seen after irradiation with MWCNTs; cells were 
either viable or found fragmented at the highest fluence levels. SWCNT showed still 
different behavior, with little evidence of any cellular bioeffects, except at the highest laser 
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exposure duration and fluence, which generated non-viable cells, some cell fragmentation, 
but no significant uptake of molecules into cells. The finding that MWCNTs enable 
efficient intracellular delivery without loss of cell viability over a range of laser fluence 
values may be of use for intracellular delivery applications. 
 In order to explain these different behaviors, we tried to correlate the bioeffects 
with peak photoacoustic pressure emitted by the nanoparticles, but found that there was no 
universal correlation when data from all three types of nanoparticles were considered 
together. This indicated that the peak photoacoustic pressure was not mechanistically 
responsible for bioeffects. Additionally, since the pressure waveforms for CB, MWCNT, 
and SWCNT were similar, with the exception of the cumulative peak pressure, this again 
suggests that photoacoustic pressure does not explain the varied bioeffects caused by the 
different types of nanoparticles. Future studies should examine the role of short-range cell-
nanoparticle interactions mediated by thermal, fluid mechanical and/or near-field acoustic 
effects and their possible role in TNET-mediated bioeffects.  
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CHAPTER 6. DISCUSSION 
Novel drug delivery techniques are essential to improve drug targeting. Specific 
targeting is needed for delivery of potentially revolutionary therapies once they reach the 
cytosol [4], [5]. However, the cell’s plasma membrane presents a barrier to the delivery of 
molecules that are polar or large in nature to be delivered by methods other than active 
transport. Active transport mechanisms can degrade the drug during the endocytotic 
pathway [8]. Physical methods are of interest due to their ability to bypass the endocytotic 
pathway by physically creating transient pores in the membrane to enable passive transport 
of molecules into the cytosol [31]. However, one of the major disadvantages of physical 
methods is that applying too much force to the cell can lead to irreversible damage and 
viability loss. Thus, efficient physical drug delivery methods balance the extent of physical 
disruption (maintaining high cell viability), while delivering molecules efficiently to the 
intracellular space.  
To balance this tradeoff, our lab has developed a novel laser-mediated method 
known as TNET. Previous studies have shown that when CB nanoparticles in suspension 
with cells and small molecules are irradiated by nanosecond pulse NIR laser energy, highly 
efficacious delivery and high viability are achieved [13], [14], [73]. First, Chakravarty’s 
studies with femtosecond and nanosecond laser pulses suggested that the carbon-steam 
reaction and the photoacoustic effects as a byproduct, were responsible for intracellular 
delivery [13]. Further studies by Sengupta showed that instead, short-range interactions 
due to cell-particle interaction (e.g. bubble contact with cell) were responsible for 
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bioeffects [23]. As such, this thesis sought to provide a more thorough understanding of 
fundamental biophysical phenomena that drive TNET. 
6.1 Role of cell mechanics in TNET 
The first study in this work sought to understand the role of cell mechanics in TNET 
and more specifically how cellular mechanics influence the outcome (i.e. intramolecular 
uptake and viability loss) of TNET. We explored cytoskeletal mechanics and cell 
membrane fluidity by altering their properties and then quantified the resulting bioeffects 
after in vitro exposures.  
We found that destabilizing the cytoskeleton with LatA led to greater intracellular 
uptake and less viability loss due to TNET. We hypothesized that the effects of cytoskeletal 
weakening may be due to an enhanced ability of the cell to recover and reseal the 
membrane. Other studies have shown that the cytoskeleton can be a physical obstacle for 
microvesicles needed for membrane fusion [93], [94] and as such destabilizing actin 
filaments can enhance membrane resealing [94], [95].  
We also used Jasplak to rigidify the cytoskeleton, with the expectation that Jasplak 
treatment would result in less intracellular uptake compared to non-treated cells. However, 
the results showed that there was no significant difference in uptake and viability loss 
compared to non-treated cells. We hypothesized that these results could be attributed to the 
conflicting effects of Jasplak present in the literature. Some studies showed that Jasplak 
can rigidify the cytoskeleton [77], [97], [98], whereas others showed that Jasplak can 
induce the opposite effect (i.e. destabilize actin) [74], [99], [100].  
 95 
In this study, we also altered plasma membrane fluidity by enriching and depleting 
cholesterol content with methyl-β-cyclodextrin (MβCD) and water-soluble cholesterol 
(WSC), respectively. The results indicate that changing membrane fluidity by altering 
cholesterol content with these reagents did not induce a significant difference in 
intracellular uptake or viability loss compared to non-treated cells for either compound 
used. From these results, we concluded that cell membrane fluidity did not play a 
significant role in uptake and viability in TNET.  
6.2 Cell-CB nanoparticle interactions drive TNET 
The second part of this work focused on understanding the parameter space of 
short-range material-laser and more specifically, how total energy input influences cell-CB 
nanoparticle interactions which drive TNET. We studied the effect of total energy input on 
this interaction by evaluating the effects of laser pulses, CB nanoparticle concentration, 
cell concentration, and medium viscosity. 
 Our studies on the effects of CB nanoparticle concentration and cell concentration 
highlighted several important aspects of TNET. First, we saw that there was a nanoparticle 
concentration threshold necessary for bioeffects and below that threshold significant 
bioeffects did not occur. This highlights several important aspects of TNET – first that 
there is a threshold CB nanoparticle concentration required for there to be bioeffects. 
Second, we also observed a laser fluence threshold (i.e. ≥ 44 mJ/cm2) for bioeffects to 
occur, regardless of CB nanoparticle concentration. Above these two thresholds, we saw 
that bioeffects increase, first as increased uptake, then increased viability loss and finally 
increased cell fragmentation.  
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Our additional studies with cell concentration and laser pulses revealed that total 
energy input per cell is a governing parameter for photoporation achieved with TNET. 
Moreover, we saw that as cell concentration decreased cellular bioeffects increased, being 
that more energy was imparted on each cell. Similarly, we saw that with increasing laser 
pulses, cellular bioeffects increased, again due to the increase in total energy input per cell. 
Taken altogether with the CB concentration and laser fluence data, we showed that total 
energy input per cell is a strong predictor of bioeffects due to TNET. 
Finally, we also studied the effect of cell medium viscosity on bioeffects. By using 
carboxymethylcellulose (CMC) we increased the viscosity of the cell medium ~13 fold and 
showed that uptake was significantly reduced in a more viscous medium compared to a 
suspension without CMC. This suggests that the short-range energy transfer induced by 
the growth of the bubble and fluid displacement due to bubble radial motion was dampened 
by the increase in viscosity and led to lesser bioeffects. Another factor could be the 
molecular diffusion was slowed and that led to reduced uptake.  
6.3 Mechanistic implications of photoacoustics 
The last part of this work investigated the TNET effects of different carbon 
materials and their mechanistic implications for TNET. Fundamentally, we were interested 
in separating bioeffects from the influence of the particle. We measured the cumulative 
pressure profiles of three carbon particle systems – CB, multi-walled carbon nanotubes 
(MWCNT) and single-walled carbon nanotubes (SWCNT). Then, we incorporated these 
particle systems in vitro and quantified the resulting bioeffects to determine if acoustics 
universally correlate to bioeffects.  
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The cellular bioeffects of CB, MWCNT, and SWCNT had different bioeffect 
‘profiles’ in vitro. First, as the laser fluence increased, CB showed a transition from cells 
with uptake to non-viable cells (i.e. PI+ cells) to fragmented cells. In contrast, cells exposed 
with MWCNT showed higher uptake levels over a greater range of fluence compared to 
CB and at even higher fluence showed fragmentation. SWCNT had little effect on cells – 
that is, there was no significant uptake or viability loss.  
From these observations, we then tried to correlate bioeffects with the particles’ 
respective acoustic profiles. Our acoustic measurements revealed that the SWCNT 
exhibited the highest cumulative peak pressure profiles compared to CB and MWCNT, in 
descending order. Since there was no universal correlation with peak pressure and resulting 
bioeffects, we hypothesized that total energy input was mechanistically more important 
than pressure output in TNET. 
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CHAPTER 7. CONCLUSIONS & RECOMMENDATIONS 
7.1 Conclusions & Contributions 
7.1.1 Conclusions 
The overall aim of this work was to provide mechanistic understanding of the 
energy transductions in TNET that impacts cells. As such, understanding the role of cellular 
mechanics, CB-cell interaction and photoacoustics in TNET was needed to enable a more 
rational approach in optimization of this drug delivery platform. First, we showed that the 
mechanical structure of the cell and its ability to repair itself after TNET is dependent on 
the cytoskeleton (actin filaments). We also showed that plasma membrane fluidity does not 
significantly influence bioeffects. Second, we showed that total energy input and total 
energy input per cell strongly influences CB-cell short-range interactions and moreover, 
these interactions are strongly dictated by CB nanoparticle concentration and laser fluence. 
This provides mechanistic insight needed before translating this platform for applications, 
for example – where the threshold for intracellular uptake and viability loss can be 
calibrated by specific nanoparticle concentrations. Lastly, we showed that the role of 
photoacoustics in TNET is minimal at best, since peak pressure does not universally 
correlate with bioeffects and that mechanistically, total energy input is more critical. This 
again supported our findings that TNET is driven by short-range CB-cell interactions, 
rather than by long-range acoustics.  
7.1.2 Contributions 
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This thesis contributed to intracellular drug delivery research in various ways. 
Leveraging nanotechnology coupled with NIR laser systems is a cutting edge platform for 
which there is growing interest [105]. More specifically, most laser-mediated 
photoporation systems use other materials (e.g. gold) for delivery, typically by a thermal 
mechanism, whereas we have uniquely studied and successfully used CB nanoparticles to 
achieve efficacious delivery and develop a mechanistic understanding of TNET that 
appears to involve mechanical, and possibly thermal, interactions. By showing that short-
range nanoparticle-cell interactions drive TNET, we laid the foundation for further 
optimization of this platform before translating into applications. In addition, by studying 
material-laser interactions, we provided the foundation for future studies which must 
consider materials properties for successful drug delivery. Overall, TNET is a novel, 
promising method to deliver small molecules into cells efficiently and once optimized, has 
potential to have great impact in the clinic and improve healthcare.  
7.2 Recommendations 
7.2.1 Boundary effects of the cuvette 
The in vitro intracellular drug delivery studies were typically conducted using a 
Pyrex cuvette system. We were curious about the extent of the cuvette’s role in TNET and 
more importantly if it had a significant role at all. As such, we conducted some preliminary 
studies to explore the consequence of the cuvette on bioeffects. The initial results 
(Appendix A) suggest that the physical boundary of TNET does in fact play an interesting 
role in observed bioeffects because of TNET. 
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First, we evaluated acoustic field effects present in the cuvette, in which a set of in 
vitro delivery experiments were conducted in a water tank. The purpose of submerging the 
cuvette with CB nanoparticles, cells, and calcein in a large bath of water was to minimize 
reflections off the glass-exterior interface normally present when the cuvette was irradiated 
in air (i.e. not submerged in water). The results show that intracellular uptake was 
significantly reduced for samples submerged and irradiated in water compared to samples 
irradiated in air (no water) (Appendix A). These preliminary results suggest that 
reverberations in the cuvette, due to acoustic energy buildup and reflections of tensile 
stresses at the glass-air interface may contribute to TNET. 
We also considered the physical effects of the cuvette walls and boundary. To vary 
the physical boundary of the cuvette wall, we irradiated CB nanoparticles, cells and calcein 
in cuvettes with different path lengths (i.e. 2.5 mm and 10 mm). The preliminary results 
show that cuvette with a longer path length (10 mm) showed a significant increase in cell 
viability compared to the 2.5 mm cuvette (Appendix A). These initial results suggest that 
the physical boundary (i.e. cuvette walls) is important to TNET and moreover, supports 
our hypothesis that TNET is mediated by short-range, local effects. Combined with the 
water tank experiments, these results make a case to better understand the physical role of 
the cuvette in TNET.  
With that, a study further exploring these cuvette effects is warranted. 
Understanding the physical boundary effects is integral for our mechanistic understanding 
of TNET and has implications for translating this platform in vivo. The next set of studies 
should attempt to answer the question of TNET’s efficacy if unconstrained and unbounded 
by the cuvette’s walls. One way to test this is to design a cuvette apparatus (e.g. consisting 
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of low density polyethylene walls or mylar film surfaces and neoprene walls) which would 
minimize acoustic boundary effects while maintaining optical transparency necessary to 
irradiate samples. An in vitro experiment can then be conducted where prior to irradiation 
the new cuvette is submerged in a water tank to further minimize acoustic reflections that 
would be present at an air-glass interface. Since it is possible that the reflections exert 
tensile stresses on the cells, if this new custom cuvette shows greater efficacy (i.e. higher 
viability and uptake) compared to the Pyrex cuvette, it would suggest that the rigid 
boundaries are an impediment to higher efficacy in TNET. Moreover, it would suggest that 
the rigid boundaries act as a ‘kill zone’, where cells near the rigid boundaries experience 
greater tensile stresses compared to cells near the cuvette interior. We observed this type 
of phenomena where the 2.5 mm cuvette exhibited greater viability loss compared to the 
10 mm cuvette when irradiated in air (i.e. not submerged in water) (Appendix A). 
Investigating the effect of rigid boundaries is critical to predicting how TNET would 
perform in vivo, where the boundaries would have a drastically different rigidity or lack 
thereof due to soft tissue. Furthermore, if less rigid interfaces lead to more intracellular 
uptake and higher viability, we could better optimize the platform for in vivo work and for 
eventual translation into the clinic.  
7.2.2 Discerning stresses experienced by the cell under TNET 
To further elucidate the biophysical basis of TNET, we need to understand the 
magnitude and type of stresses experienced by the cell. This thesis suggests that TNET is 
mediated by short-range cell-nanoparticle interaction due in part to the presence and 
growth of vapor bubbles. In conjunction with the preliminary cuvette boundary work and 
the breadth of parameters studied for the short-range effects, it is possible that the cells 
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experience mechanical (i.e. tensile, compressive, shear) stresses and/or thermal stresses 
from point sources (i.e. local effects from CB nanoparticles).  
Our acoustic measurements of irradiated nanoparticle streams (CHAPTER 5) 
showed a mostly compressive acoustic profile, in contrast to other physical methods which 
leverage acoustic stresses for poration. For example, cavitation events in ultrasound drug 
delivery methods release acoustic waves with tensile and compressive components, where 
the compressive component of these waves is reported to lead to subsequent cellular or 
tissue damage [60], [61].  
To discern the mechanical stresses experienced by the cell in TNET, a combination 
of high speed imaging and computational efforts could provide more insight. There are 
some systems in the literature which have coupled external imaging with high resolution 
microscopy and pulsed lasers [56], [57], but the challenge is often reconciling spatial 
resolution with temporal resolution. For instance, high speed imaging has been used to 
observe effects of sonoporation [128], [129] but the bubble lifetime existed well beyond 
what we have seen in our studies (i.e. 1-10’s of microseconds vs hundreds of nanoseconds). 
Thus, a more pragmatic approach would be to employ computational methods coupling 
theoretical predictions with experimental observations.  
There have been previous attempts to simulate the behavior of phospholipids in the 
cell membrane upon impact of shock waves using molecular dynamics (MD) [130]–[132] 
and coarse grain MD methods [133]. The acoustic emissions in our system do not have 
characteristics of shock waves, but nevertheless the literature can provide a basis for 
simulating cellular response to stress fronts. One limitation to computational methods is 
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that the entire cellular response cannot be captured by current techniques. That is, current 
computational capabilities can either capture lipid dynamics or continuum mechanics of 
the cell, but not both length-scales. Simulations can still be useful though to comprehend 
cellular response to stress at the membrane level. Moreover, if we can understand how the 
membrane deforms under stresses from TNET, we can better predict bioeffects associated 
with TNET. Computational models can also be used to simulate stress thresholds needed 
to transiently porate the membrane and those thresholds can then be correlated to extent of 
intracellular uptake and viability based on various input parameters (e.g. laser fluence, CB 
nanoparticle concentration). 
From our membrane fluidity studies (Chapter 3), we hypothesized that energy 
transduction during TNET is primarily mechanical in nature; however, we do not have 
direct evidence to rule out a thermal mechanism. To test the possibility of a thermal 
mechanism, probes that could indicate a temperature change or lipid phase transition in the 
cell membrane should be considered. There have been some studies which have used FTIR 
analysis [134] and fluorescent probes such as diphenylhexatriene (DPH) [135]–[137] for 
fluorescence anisotropy analysis to quantify lipid phase changes. These types of probes 
may serve as assays to determine if TNET has a strong thermal energy component 
necessary for cell poration and drug delivery.  
Finally, there is also interest in discerning if shear stresses lead to permeabilization 
and molecular delivery in TNET. Other work with needle loading [138] and microfluidic 
devices [139] showed that shear forces can cause reversible permeabilization. It is possible 
that during TNET, cells experience shear stresses which causes bioeffects. McNeil’s work 
[138] for example, showed that adding poloxamers (i.e. pluronics) preserved cell viability 
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after shear loading cells to deliver macromolecules. Interestingly, previous work using 
TNET also showed that using poloxamers enabled greater cell viability compared to 
exposed samples without the treatment [80]. Further studies comparing and quantifying 
shear stresses of TNET to other methods would be useful to better elucidate the impact of 
shear on permeabilization of cells for drug delivery.   
7.2.3 Length-scale of TNET effects 
Our studies have shown that long-range effects (i.e. cumulative acoustic output) is 
not likely in TNET (Chapter 5). Additionally, our further studies have shown that short-
range effects (i.e. cell-CB interaction) are most likely dominant (Chapter 4). Based on our 
observations, we hypothesize that energy transduction from the laser-activated carbon 
nanoparticle is occurring on the order of 1 – 10 µm (Chapter 5). However, in the scope of 
this thesis, we have not been able to definitively provide a length-scale of TNET effects. 
Thus, to further explore cell-CB interaction and discern the length-scale of effects, 
individual cell-particle interactions should be tested. This could be conducted with gel 
microdroplets, which have been previously used to isolate single cells and molecules into 
agarose microdroplets and quantified with flow cytometry [140]. These droplets can be 
used to study the local environment by studying individual cellular effects in suspension 
with CB nanoparticles.   
7.2.4 Nanoparticle studies and criteria for future TNET efforts 
7.2.4.1 Carbon studies 
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Different carbon nanoparticles have been studied in this thesis (i.e. CB, SWCNT, 
MWCNT). We tested CNTs with a length dimension on the order of microns, but shorter 
SWCNT and MWCNTs are readily available. An in vitro exposure study to compare 
bioeffects as a result of differing aspect ratios would be interesting, considering possible 
differences in timescale for heat transfer and subsequent bubble growth due to changes in 
nanotube length.  
CB’s broadband absorption in the NIR is related to its electron band structure and 
the electronic states upon irradiation. Understanding this laser-CB interaction on the 
electronic and photonic level may provide more insight into the transfer of energy upon 
irradiation. Additionally, it would be worthwhile to understand the absorption behavior of 
other carbon allotropes such as diamond [141], graphene [142], and other fullerene-based 
[143], [144] nanoparticles and test their performance in vitro to understand if a carbon 
nanoparticle is essential to the bioeffects achieved with TNET.  
7.2.4.2 Criteria for nanoparticles in vivo 
Prior to translating TNET in vivo, it is important to understand the role of materials 
properties in TNET. Due to difficulties in uniform dispersion of the aggregates, constraints 
on size (due to aggregation) and issues of dispersion with previous attempts at in vivo work 
[145], it is not yet known if CB nanoparticles are the ideal candidate for future TNET work. 
Thus, testing and designing other candidate nanoparticles in vitro will be critical prior to 
in vivo studies.  
Nanoparticle size is an important parameter for in vivo work. Particles < 5 nm in 
diameter can clear rapidly in the renal system [146], but reducing the size of the 
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nanoparticles also decreases its melting point [147] and can lead to morphological changes 
upon irradiation. For tumor applications, nanoparticles ~50 nm in diameter can penetrate 
complicated vasculature, but that is also dependent on surface charge and particle 
morphology [148]. To compare, our CB nanoparticles have a primary particle size of 25 
nm but aggregate into agglomerates on the order of ~200 nm due to van der Waals forces. 
Thus, testing other materials which can be uniformly dispersed and resist agglomeration is 
necessary for practical translation of TNET in vivo.   
Next, significant work on particle modification for in vivo stability is necessary. 
Studies have shown that surface modification of SWCNT [149], [150] and MWCNT [114], 
[115] can be advantageous for drug delivery. These modification strategies involve surface 
PEGylation of CNTs for passivation needed for stable circulation [115] and for effective 
penetration into tissues [151]–[153]. Alternatively, it may be worth exploring conjugation 
of surface ligands to nanoparticles with the purpose of selective tumor receptor binding for 
specific targeting prior to laser irradiation.  
Lastly, candidate nanoparticles needed to strongly absorb in the NIR. The NIR 
region is highly advantageous for clinical applications since NIR is weakly absorbed by 
tissue and can thus be focused several centimeters through tissue [62] for tumor treatment. 
Moreover, effective NIR absorption is necessary for rapid nanoparticle heat, expansion and 
vaporization in TNET. 
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APPENDIX A. BOUNDARY EFFECTS OF CUVETTE 
To consider all the components of our in vitro laser-mediated system, we were 
interested in the effects of the cuvette on TNET. More specifically, we wanted to 
investigate if the rigid physical boundaries of the cuvette walls (i.e. path length) contributed 
to energy transfer processes during irradiation of the CB nanoparticles.  
We conducted a series of preliminary studies to address the role of cuvette boundary 
effect in TNET. First, we compared bioeffects of samples irradiated in air (i.e. normal 
exposure conditions) with bioeffects of samples irradiated in a water tank. Next, we tested 
the effects of cuvette dimensions on TNET by exposing samples in a cuvette with a longer 
path length (i.e. 10 mm) compared to our standard cuvette (i.e. 2.5 mm). The compelling 
results from this study provide a foundation for further cuvette boundary effect studies 
necessary to fully understand the in vitro environment prior to transitioning in vivo. 
A.1 Methods 
A.1.1 Nanoparticle Prep 
CB nanoparticles were prepared as previously described [14] with a stock 
concentration of 0.4 g/L. Dynamic light scattering measurements conducted by us revealed 
that the nanoparticle assembled into clusters with an effective diameter of 201.4 ± 5.5 nm 
(n=10) and a dispersity of 0.15 ± 0.04 nm (n=10 replicates) (ZetaSizer Nano, Malvern 
Instruments, Malvern, UK). Solutions were further diluted with DI water to obtain lower 
CB concentrations.  
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A.1.2 Laser system 
A Nd:YAG solid-state laser (Continuum Powerlite II Plus, Continuum, San Jose, 
CA) was used to apply 5-9 ns pulses of 1064 nm wavelength at a frequency of 10 Hz (i.e. 
10 pulses per second) to cell suspensions. Pulse fluence was varied by changing the 
amplifier voltage settings of the laser. The initial Super-Gaussian 12 mm wide beam was 
passed through an 8 mm aperture to create a pseudo-flat top profile to achieve a more 
homogeneous distribution of the laser energy.  
A.1.3 Cell culture & in vitro exposures 
Human prostate cancer cells (DU145, American Type Culture Collection, 
Manassas, VA, USA) were cultured as monolayers in a humidified atmosphere of 95% air 
and 5% CO2 at 37°C in RPMI-1640 medium (Cellgro, Herndon, VA, USA) supplemented 
with 100 g/mL penicillin-streptomycin (Cellgro) and 10% (v/v) heat inactivated fetal 
bovine serum (FBS) (Corning, Palo Alto, CA, USA). Cells were harvested at 80-90% 
confluence for experiments by trypsin/EDTA (Cellgro) digestion, washed with serum and 
then re-suspended in RPMI at a cell concentration of 106 cells/ml. 
Cells were transferred to Pyrex glass cuvettes with a 2.5 mm path length, and in 
some cases a 10 mm path length for exposure. Harvested cells were transported in 1.5 ml 
microcentrifuge tubes and stored on ice until exposure. Exposed cuvettes contained 520 
μL of cells suspended in RPMI, in addition to carbon nanoparticle solutions added at final 
concentrations of 3.1, 25 mg/L and 157 mg/L. High purity calcein (Molecular Probes, 
Eugene, OR, USA) was added as an uptake marker at a final concentration of 10 μM. 
Following exposure, the contents were transferred back into the microcentrifuge tubes with 
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a transfer pipette and stored on ice to reduce uptake due to endocytosis. To label nonviable 
cells post-irradiation, propidium iodide (Invitrogen, Grand Island, NY, USA) was added at 
a concentration of 13.5 μM and cells were incubated for 10 minutes. Samples were washed 
at least 3 times with phosphate buffer saline (PBS) to remove excess fluorescence from the 
bulk solution. 
A.1.4 Analysis 
 A flow cytometer (BD Accuri, BD Biosciences, San Jose, CA) quantified bioeffects 
in terms of live cells with intracellular uptake (i.e. intact cells with green fluorescence of 
calcein loading and without red fluorescence of propidium iodide staining) and non-viable 
cells (i.e. intact cells with propidium iodide staining). Calcein fluorescence was measured 
with a 530/28 nm bandpass filter and propidium iodide (PI) was measured with a 670 nm 
longpass filter. Samples were run at a constant flow rate of 35 μL/min for 1 min.  
 A negative control containing cells only in RPMI was used to construct a cell 
population gate in the forward-scattered and side-scattered analysis. Cells within this gate 
were intact cells, whereas events with a lower forward-scatter and higher side-scatter signal 
were considered to be dead cells. To account for possible cell loss due to cell fragmentation 
and necrotic death, the number of PI-negative cells for each exposed sample was compared 
to the PI-negative cells for the sham [80].  
A.2 Results 
First, we evaluated effects of the acoustic field in the cuvette with a series of 
experiments in a water tank. Samples in the cuvette were submerged in a water tank to 
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minimize reflections off the glass-exterior interface usually present in normal exposure 
conditions (i.e. cuvette exposed in air). Samples irradiated in water showed significantly 
lower intracellular uptake at both 44 mJ/cm2 and 88 mJ/cm2 when compared to samples 
exposed in air (Figure A.1).  
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Figure A.1: Cells in cuvette exposed to 600 pulses at 44 and 88 mJ/cm2 in air and 
submerged in water: a) uptake, b) non-viable cells, c) fragmented cells, and d) total 
bioeffects (uptake, non-viable, fragmented). Asterisks (*) indicate statistical 
significance (ANOVA, *p< 0.05, ****p< 0.0001). Data show average ± SD (n = 3).  
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The effects of the physical boundary (i.e. walls / path length) of the cuvette was 
also investigated. Experiments were conducted where the same front surface area of the 
cuvette was the same, but the thickness or the path length of the cuvette was altered from 
2 mm to 10 mm (5x the initial path length). Cells, carbon black, and calcein were added to 
the more voluminous cuvettes (i.e. 10 mm) by scaling the volumes with the original 
cuvette. Samples were exposed for the shortest number of pulses which we observed 
bioeffects with a final CB concentration of 25 mg/L (Error! Reference source not found.).  
The preliminary results indicate that intracellular uptake increased for samples 
exposed in the 10 mm cuvette compared to the 2.5 mm cuvette (Figure A.2a). There was 
no significant difference in viability loss (PI+ cells) between the 2.5 mm and 10 mm 
cuvettes (Figure A.2b). Cells exposed in the 10 mm did, however, exhibit significantly 
less fragmentation compared to the 2.5 mm cuvette (Figure A.2c). There was no significant 
difference in total bioeffects between the 2.5 mm and 10 mm cuvettes (p = 0.9524) (Figure 
A.2d). These initial results suggest that the physical boundary (i.e. cuvette walls) is 
important to TNET and moreover, supports our hypothesis that TNET is mediated by short-
range, local effects.  
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Figure A.2: Percentage of cells with a) uptake, b) non-viable, c) fragmented, and d) 
total bioeffects (uptake, non-viable, fragmented) after exposure to 150 pulses at 88 
mJ/cm2 with 25 mg/L CB nanoparticles with cuvette thicknesses changed from 2.5 to 
10 mm. Asterisks (*) indicate statistical significance (ANOVA, *p < 0.05, **p < 0.01). 




The preliminary results for the water tank and cuvette path length experiments 
suggest further investigation is needed to reconcile the role of the cuvette in TNET. We 
saw that by minimizing reflections at the glass-air interface, less bioeffects occurred. This 
suggests that pressure may be reverberating inside the cuvette and applies shear and/or 
tensile forces on cells, leading to viability loss. Additionally, the cuvette path length 
experiments seem to indicate that TNET is a local effect [23] limited by physical 
boundaries, since we saw that by increasing the path length intracellular uptake increased 
and fragmentation was significant reduced. Further studies to better understand these 
cuvette effects are highly warranted.  
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APPENDIX B. CALCULATIONS OF CB NANOPARTICLE 
HEATING, ENERGY ABSORBED AND BUBBLE SIZE 
B.1 Calculating energy absorbed (Qin) 
 Using Mie scattering theory analyses from previous work [23] allows us to calculate 
Qin. Let us calculate Qin for 0.39 mg/L CB nanoparticle concentration at 44 mJ/cm
2. Mie 
scattering calculations were done with an online calculator [154].  
Input Parameters: 
 Sphere Diameter = 0.025 µm 
 Wavelength in Vacuum = 1.064 nm 
 Index of Refraction of media (water) = 1.33 
 Carbon Refractive Index = 2-0.29i [155] 
 Number of Angles =100 
 Concentration = Number of spheres in one aggregate/ Volume of each aggregate  
 = 31751.4 spheres/cm3 
Output Parameters: 
 Scattering Cross Section = 1.27 x 10-8 µm2 
 Backscattering Cross Section = 1.90 x 10-8 µm2 
 Extinction Cross Section = 2.1 x 10-5 µm2 
 
Total Scattering Cross Section = Scattering Cross Section + Backscattering Cross 
Section 
 115 
 = 3.18 x 10-8 µm2 
 
Total Absorption = Total Extinction – Total Scattering = 2.10 x 10-5 µm2 
Number of spherules per aggregate = 133 
Total absorption area in 1 aggregate = Total Number of spherules in each aggregate x 
Absorption by each spherule  
 = 133 x (2.10 x10-5 µm2) = 2.79 x 10-3 µm2 
 
Total scattering by 1 aggregate = Total number of spherules in each aggregate2 x 
Scattering by each spherule  
 = 1332 x (3.18 x 10-8 µm2) =5.62 x 10-4 µm2 
 
For a 0.39 mg/L carbon solution: 
Total number of spherules = 1.48 x 1010      
Total absorption by solution = Total Number of spherules x Absorption by each 
spherule 
 = 3.10 x 10-7 m2 
 
Total scattering by solution = Total number of spherules per aggregate2 x Scattering per 
spherule x Total number of aggregates = Total Number of Spherules x Total number of 
spherules per aggregate x Scattering per spherule = 6.25 x 10-8 m2 
 
Absorbed Energy =Total absorption area / Total area  
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 = ((3.10 x 10-7 m2) x 100)/(4 x 10-4 m2) = 0.08% 
 
Scattered Energy =Total scattering area / Total area  
 = ((6.25 x 10-8 m2) x 100)/(4.0 x 10-4 m2) = 0.016% 
 
Energy Attenuation = Absorbed % + Scattered % = 0.093% 
Total laser energy at 44 mJ/cm2: 175 mJ 
Qin: (Absorbed energy (%) x Total laser energy) / 100 =0.136 mJ/shot  
B.2 Calculating CB nanoparticle heating 
Again, let us continue to use a 0.39 mg/L CB nanoparticle concentration exposed to 
a laser fluence of 44 mJ/cm2 as an example. We will now calculate the peak particle 
temperature based on previous work [23].  
Total mass of CB in cuvette = 0.39 mg/L x 0.563 mL = 2.19 x 10-7 g 
Heat capacity of CB = 0.7 J/gºC 
Peak particle temperature = (Qin) / (Total mass of CB x Cp) = 884 ºC 
 
B.3 Calculating vapor-bubble size 
Now let’s calculate the vapor-bubble size based on the above parameters: 
Heat capacity of water = 4.184 J/gºC 
ΔT = (100 – 23) ºC = 77 ºC 
ΔHvaporization = 2260 kJ/mol 
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Moles of water produced (n) = ((Qin – Total mass x Cpcarbon x ΔT) / (Cpwater x ΔT + 
ΔHvaporization)) = 5.25 x 10-11 kg 
 
Mass of water vapor per NP = Moles of water produced / Total # aggregates 
    = (5.25 x 10-11 kg) / (1.1 x 108) 
    = 4.72 x 10-19 kg 
 
Steam specific volume = 1.67 m3/kg 
Volume of vapor = Mass of water vapor per NP x Steam specific volume 
  = 7.88 x 10-19 m3 
 
Radius of vapor = (Volume of vapor x 0.75) / (π1/3) 
      = 573 nm 
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0
5 0 0
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Figure B.1: a) Calculated peak particle temperature with increasing laser fluence 
shows a linear relationship with fluence and temperature. b) Calculated bubble size 
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with increasing laser fluence shows a nonlinear relationship with fluence and bubble 
radius.  
B.3 Total energy input per cell  
Table B.1: Total energy input per cell calculations for all CB nanoparticle 
concentrations and laser pulses tested based on Figure 4.6. Asterisks (*) indicate 
number of cells for a given 520 µL volume in the cuvette, based on a cell concentration 








pulses # Cells* 
Total energy 
absorbed per cell 
(mJ/cell) 
25 
88 1.7E+01 1 5.2E+05 3.4E-05 
88 1.7E+01 10 5.2E+05 3.4E-04 
88 1.7E+01 50 5.2E+05 1.7E-03 
88 1.7E+01 150 5.2E+05 5.0E-03 
88 1.7E+01 300 5.2E+05 1.0E-02 
88 1.7E+01 600 5.2E+05 2.0E-02 
88 1.7E+01 1800 5.2E+05 6.0E-02 
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88 1.1E+02 1 5.2E+05 2.1E-04 
88 1.1E+02 10 5.2E+05 2.1E-03 
88 1.1E+02 50 5.2E+05 1.1E-02 
88 1.1E+02 150 5.2E+05 3.2E-02 
88 1.1E+02 300 5.2E+05 6.3E-02 
88 1.1E+02 600 5.2E+05 1.3E-01 




Table B.2: Total energy input per cell calculations for all CB nanoparticle 
concentrations and cell concentrations tested based on Figure 4.7. Asterisks (*) 
indicate number of cells for a given 520 µL volume in the cuvette, based on a cell 














88 3.3E-02 600 5.2E+04 3.8E-04 
88 3.3E-02 600 2.6E+05 7.5E-05 
88 3.3E-02 600 5.2E+05 3.8E-05 
88 3.3E-02 600 1.0E+06 1.9E-05 
88 3.3E-02 600 5.2E+06 3.8E-06 
3.1 
88 2.2E+00 600 5.2E+04 2.5E-02 
88 2.2E+00 600 2.6E+05 5.0E-03 
88 2.2E+00 600 5.2E+05 2.5E-03 
88 2.2E+00 600 1.0E+06 1.3E-03 
88 2.2E+00 600 5.2E+06 2.5E-04 
25 
88 1.7E+01 600 5.2E+04 2.0E-01 
88 1.7E+01 600 2.6E+05 4.0E-02 
88 1.7E+01 600 5.2E+05 2.0E-02 
88 1.7E+01 600 1.0E+06 1.0E-02 
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